Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 43
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomes

  • Borges, Maria Carolina
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Lawlor, Deborah
Background: Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear. Methods: We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women. Results: All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation. Conclusions: Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications. Funding: Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust., This study was supported by the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00032/05), British Heart Foundation (AA/18/1/34219), the European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545), the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206 (LifeCycle), the US National Institutes of Health (R01 DK10324, U01 HG004415), the Bristol NIHR Biomedical Research Centre, and the Research Council of Norway through its Centres of Excellence funding scheme (project number 262700), and the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author-Accepted Manuscript version arising from this submission. MCB has received support from MRC Skills Development Fellowship (MR/P014054/1) and the University of Bristol Vice-Chancellor’s Fellowship. DAL is a British Heart Foundation Chair (CH/F/20/90003) and NIHR Senior Investigator (NF-0616–10102). JT is supported by an Academy of Medical Sciences (AMS) Springboard Award, which is supported by the AMS, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK [SBF004\1079]. RMF was funded by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (WT104150) and is now funded by a Wellcome Trust Senior Research Fellowship (WT220390). RG received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002), and the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109). VWVJ received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). XL received support from the Nordic Center of Excellence in Health-Related e-Sciences. LS reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899). BF was supported by an Oak Foundation Fellowship and by a grant from the Novo Nordisk Foundation (12,955). MCM has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). TAB is supported by the Medical Research Council (MRC) (UK) (MR/K501281/1), the NHMRC (Australia) (GNT1183074 and GNT1157714), and the British Heart Foundation Accelerator Award at the University of Bristol (AA/18/1/34219) and works in/is affiliated with a unit that is supported by the UK Medical Research Council (MC_UU_00011/6). LB is a senior research scholar from the Fonds de la recherche du Québec-Santé (FRQ-S) and a member of the FRQ-S-funded Centre de recherche du CHUS. MFH was supported by an American Diabetes Association (ADA) Pathways Accelerator Award (1–15-ACE-26). SEH and MCM are partly funded by the Research Council of Norway (project no. 320656) and through its Centres of Excellence funding scheme (project No 262700). JW and RMc are supported by the National Institute for Health and Care Research under its Applied Research Collaboration, Yorkshire and Humber (NIHR200166).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Association of environmental noise exposure with cortisol levels in children from eight European birth cohorts

  • Arregi, Ane
  • Guxens Junyent, Mònica
  • Nieuwenhuijsen, Mark J.
  • Vrijheid, Martine
  • Lertxundi, Nerea
Environmental noise is a major environmental risk factor for public health. According to the noise reaction model the release of stress hormones like cortisol in response to noise exposure, plays a key role in the development of noise-induced health effects. We aimed to study the association between environmental noise with both acute (UCC) and cumulative (HCC) cortisol levels in children 5-12 years of age. To do so, we analysed data from the HELIX cohort -with spot UCC data- and from the Generation R and INMA cohorts (Gipuzkoa and Sabadell) -with HCC data. The analytical sample involved: 750 HELIX children (mean age = 7.75), 1326 Generation R children (mean age = 6.06), 111 INMA-Sabadell children (mean age = 8.75) and 288 INMA-Gipuzkoa children (mean age = 7.85). Day-evening-night equivalent (Lden) environmental noise exposure during the year of the follow-up was estimated in the addresses of participants, using existing noise maps. Directed acyclic graphs (DAGs) were used to identify appropriate covariates and reduce the chance for biased estimation. We used mixed-effects modelling and linear modelling to examine the association between Lden and cortisol concentration using complete case analyses. None of the models reached the statistical significance. We observed no correlation between HCC and UCC in INMA-Sabadell participants, for whom both urinary and hair cortisol data were available. Future research should prioritize investigating the effects of environmental noise on HCC, as it may serve as a more reliable indicator for assessing associations with chronic exposures. Additionally, future studies on noise-induced health effects in children should incorporate other biomarkers of stress and chronic inflammation to provide a more comprehensive understanding of these associations., The study was supported by the European Community's Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583; LongITools, grant agreement No 874739). Cortisol and related Glucocorticosteroids were measured within the HELIX cohorts as part of the UK Research and Innovation METAGE project (Grant ref: MR/S03532X/1). We further acknowledge funding from Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS464,445PI13/02187, FIS-PI18/01142 include FEDER funds, Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds, CPII18/00018), CIBERESP, Department of Health of the BasqueGovernment (2005111093, 2009111069, 2013111089 and 2015111065), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001, DFG15/221 and DFG89/17), Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), EU Commission (261357, 308333, 603794 and 634453). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. VJ received funding from a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report. BiB receives funding from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024391/1); the British Heart Foundation (CS/16/4/32482); a Wellcome Infrastructure Grant (WT101597MA); the National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber (NIHR200166). The National Institute for Health Research Clinical Research Network provided research delivery support for this study. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DRG), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007–2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). The “Rhea” project was financially supported by European projects (EU FP6–2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211250 Escape, EU FP7–2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU-FP7-HEALTH-2012 Proposal No 308333 HELIX, ATHLETE) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–2015). The funding bodies have not affected in any way the study and the presented results. KANC was funded by the grant of the Lithuanian Agency for Science Innovation and Technology (6-04-2014_31V-66). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts

  • Abellan, Alicia
  • Garcia-Esteban, Raquel
  • García Aymerich, Judith
  • Sunyer Deu, Jordi
  • Vrijheid, Martine
  • Casas Sanahuja, Maribel
Background: In utero exposure to bisphenols, widely used in consumer products, may alter lung development and increase the risk of respiratory morbidity in the offspring. However, evidence is scarce and mostly focused on bisphenol A (BPA) only. Objective: To examine the associations of in utero exposure to BPA, bisphenol F (BPF), and bisphenol S (BPS) with asthma, wheeze, and lung function in school-age children, and whether these associations differ by sex. Methods: We included 3,007 mother-child pairs from eight European birth cohorts. Bisphenol concentrations were determined in maternal urine samples collected during pregnancy (1999-2010). Between 7 and 11 years of age, current asthma and wheeze were assessed from questionnaires and lung function by spirometry. Wheezing patterns were constructed from questionnaires from early to mid-childhood. We performed adjusted random-effects meta-analysis on individual participant data. Results: Exposure to BPA was prevalent with 90% of maternal samples containing concentrations above detection limits. BPF and BPS were found in 27% and 49% of samples. In utero exposure to BPA was associated with higher odds of current asthma (OR = 1.13, 95% CI = 1.01, 1.27) and wheeze (OR = 1.14, 95% CI = 1.01, 1.30) (p-interaction sex = 0.01) among girls, but not with wheezing patterns nor lung function neither in overall nor among boys. We observed inconsistent associations of BPF and BPS with the respiratory outcomes assessed in overall and sex-stratified analyses. Conclusion: This study suggests that in utero BPA exposure may be associated with higher odds of asthma and wheeze among school-age girls., The research leading to these results has received funding from Instituto de Salud Carlos III and European Union’s FEDER funds (CP16/00128 – the ENDOLUNG project, and PI17/01194 – the INMA-Ado-Respi Project), the European Community’s Seventh Framework Programme (FP7/2007–206) under grant agreement no 308,333 - the HELIX project –, and from the EC’s Horizon 2020 research and innovation programme under grant agreement No 874,583 – the ATHLETE project. Generation R: This study was funded by The Erasmus MC, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. The project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583). Dr. Vincent Jaddoe received a grant from the European Research Council (ERC-2014-CoG-648916). This study was supported by grant R01-ES022972 and R01-ES029779 from the National Institutes of Health, USA. The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report. INMA Gipuzkoa: This study was funded by grants from Instituto de Salud Carlos III (FIS-PI13/02187 and FIS-PI18/01142 incl. FEDER funds), CIBERESP, Department of Health of the Basque Government (2015111065), and the Provincial Government of Gipuzkoa (DFG15/221) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain). INMA Sabadell: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), European Commission (261357, 308333, 603,794 and 634453). Alicia Abellan holds a LifeCycle fellowship, funded from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206. Maribel Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and co-funded by European Social Fund “Investing in your future“. We acknowledge support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (2018–000806-S), and support from the Generalitat de Catalunya through the CERCA Program. INMA Valencia: INMA Valencia was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/00663, and PI19/1338; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), Alicia Koplowitz Foundation, and Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15–244, UGP-15–249, and AICO/2020/285). BiB: This report is independent research funded by the National Institute for Health Research Yorkshire and Humber ARC (NIHR200166) and BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA). The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. EDEN: The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007–2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. RHEA: The Rhea project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211,250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226,285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308,333 HELIX, H2020 LIFECYCLE, grant agreement No 733206, H2020 ATHLETE, grant agreement No 874583), and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–15). Additional funding from NIEHS supported Dr Chatzi (R01ES030691, R01ES029944, R01ES030364, R21ES029681, R21ES028903, and P30ES007048). The funding sources had no involvement in the study design, the collection, analysis and interpretation of data or in the writing of the report and in the decision to submit the article for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children

  • van Meel, Evelien R.
  • Casas Sanahuja, Maribel
  • Kogevinas, Manolis
  • Sunyer Deu, Jordi
  • Duijts, Liesbeth
Background: Early-life respiratory tract infections might affect chronic obstructive respiratory diseases, but conclusive studies from general populations are lacking. Our objective was to examine if children with early-life respiratory tract infections had increased risks of lower lung function and asthma at school age. Methods: We used individual participant data of 150 090 children primarily from the EU Child Cohort Network to examine the associations of upper and lower respiratory tract infections from age 6 months to 5 years with forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC, forced expiratory flow at 75% of FVC (FEF75%) and asthma at a median (range) age of 7 (4-15) years. Results: Children with early-life lower, not upper, respiratory tract infections had a lower school-age FEV1, FEV1/FVC and FEF75% (z-score range: -0.09 (95% CI -0.14- -0.04) to -0.30 (95% CI -0.36- -0.24)). Children with early-life lower respiratory tract infections had a higher increased risk of school-age asthma than those with upper respiratory tract infections (OR range: 2.10 (95% CI 1.98-2.22) to 6.30 (95% CI 5.64-7.04) and 1.25 (95% CI 1.18-1.32) to 1.55 (95% CI 1.47-1.65), respectively). Adjustment for preceding respiratory tract infections slightly decreased the strength of the effects. Observed associations were similar for those with and without early-life wheezing as a proxy for early-life asthma. Conclusions: Our findings suggest that early-life respiratory tract infections affect development of chronic obstructive respiratory diseases in later life, with the strongest effects for lower respiratory tract infections., A comprehensive list of grant funding is available on the ALSPAC website (www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). BAMSE: BAMSE was funded by the Swedish Research Council, the Swedish Heart Lung Foundation, ALF Region Stockholm and SFO Epidemiology Karolinska Institutet. E. Mélen is supported by a European Research Council grant (TRIBAL, 757919). BiB (Born in Bradford): BiB is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all the participants, practitioners and researchers who have made BiB happen. The BiB study presents independent research commissioned by the National Institute for Health Research Collaboration for Applied Health Research and Care (NIHR CLAHRC) and the Programme Grants for Applied Research funding scheme (RP-PG-0407-10044). Core support for BiB is also provided by the Wellcome Trust (WT101597MA). BILD: This study was funded by the Swiss National Science Foundation (320030_163311). CoNER: Funds were obtained from the special programme (Programmi speciali – Art.12 bis, comma 6 D.lgs.229/99 Sanitaria e della Vigilanza sugli Enti) funded by the Italian Ministry of Health. Approval for the study was obtained from the Ethics Committee of the S. Orsola-Malpighi Teaching Hospital in April 2004 (52/2004/U/Tess). COPSAC 2000 and COPSAC 2010: All funding received by COPSAC is listed on www.copsac.com. The Lundbeck Foundation (R16-A1694), Ministry of Health (903516), Danish Council for Strategic Research (0603-00280B) and Capital Region Research Foundation have provided core support to the COPSAC research centre. We express our deepest gratitude to the children and families of the COPSAC 2000 and COPSAC 2010 cohort studies for all their support and commitment. We acknowledge and appreciate the unique efforts of the COPSAC research team. DNBC (Danish National Birth Cohort): The authors would like to thank the participants, the first Principal Investigator of DNBC, Jørn Olsen, the scientific managerial team and DNBC secretariat for being, establishing, developing and consolidating the DNBC. The DNBC was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, Pharmacy Foundation, Egmont Foundation, March of Dimes Birth Defects Foundation, Health Foundation and other minor grants. The DNBC Biobank has been supported by the Novo Nordisk Foundation and Lundbeck Foundation. Follow-up of mothers and children has been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B), Lundbeck Foundation (195/04, R100-A9193), Innovation Fund Denmark 0603-00294B (09-067124), Nordea Foundation (02-2013-2014), Aarhus Ideas (AU R9-A959-13-S804), University of Copenhagen Strategic Grant (IFSV 2012) and Danish Council for Independent Research (DFF-4183-00594, DFF-4183-00152). A. Pinot de Moira is funded by a Lundbeck Foundation grant (R264-2017-3099). EDEN: We thank the EDEN mother–child cohort study group (I. Annesi-Maesano, J.Y. Bernard, J. Botton, M.A. Charles, P. Dargent-Molina, B. de Lauzon-Guillain, P. Ducimetière, M. de Agostini, B. Foliguet, A. Forhan, X. Fritel, A. Germa, V. Goua, R. Hankard, B. Heude, M. Kaminski, B. Larroque†, N. Lelong, J. Lepeule, G. Magnin, L. Marchand, C. Nabet, F. Pierre, R. Slama, M.J. Saurel-Cubizolles, M. Schweitzer and O. Thiebaugeorges). We thank all funding sources for the EDEN study (not allocated for the present study but for the cohort): Foundation for Medical Research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 programme), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, MeDALL projects), Diabetes National Research Program (in collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l'Education Nationale complementary health insurance (MGEN), French national agency for food security, and French speaking association for the study of diabetes and metabolism (ALFEDIAM). The funding source had no involvement in the conception of the present study. FLEHS: This study was conducted within the framework of the Flemish Centre of Expertise on Environment and Health, funded by the Dept of the Environment of the Flemish Government, Flemish Agency of Care and Health, and Flemish Dept of Economy, Science and Innovation. GASPII: The GASPII cohort was funded by the Italian Ministry of Health (2001), the research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement 261357 (MeDALL). Generation R: This study was funded by Erasmus MC Rotterdam, Erasmus University Rotterdam and the Netherlands Organisation for Health Research and Development. V.W.V. Jaddoe received a grant from the European Research Council (ERC-2014-CoG-648916). L. Duijts received funding from cofunded ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL), Horizon 2020 (696295; 2017), the Netherlands Organisation for Health Research and Development (ZonMw; 529051014; 2017), Science Foundation Ireland (SFI/16/ERA-HDHL/3360), and European Union (ALPHABET project). The project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206, 2016; EUCAN-Connect 824989; ATHLETE, 874583). The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data or writing of this report. Generation XXI: Generation XXI was supported by the European Regional Development Fund (ERDF) through the Operational Programme Competitiveness and Internationalization and national funding from the Foundation for Science and Technology (FCT), Portuguese Ministry of Science, Technology and Higher Education, and by the Unidade de Investigação em Epidemiologia – Instituto de Saúde Pública da Universidade do Porto (EPIUnit) (UIDB/04750/2020), Administração Regional de Saúde Norte (Regional Dept of Ministry of Health) and Fundação Calouste Gulbenkian. A.C. Santos is founded by FCT Investigator contracts IF/01060/2015. GINI: The GINIplus study was mainly supported for the first 3 years by the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum München (former GSF) (observational arm). The 4- and 6-year follow-up examinations of the GINIplus study were covered from the respective budgets of the five study centres (Helmholtz Zentrum München (former GSF), Research Institute at Marien-Hospital, Wesel, LMU Munich, TU Munich and from 6 years onwards also from IUF – Leibniz Research Institute for Environmental Medicine at the University of Düsseldorf). HUMIS: We thank all mothers for participating in the HUMIS study. HUMIS was funded by a grant from the Norwegian Research Council (226402). The HUMIS study was approved by the Norwegian Data Inspectorate (2002/1398) and by the Regional Ethics Committee for Medical Research in Norway (S-02122), and the specific use in the current study was approved by the Ethics Committee as well (2010/1259/REK sør-øst). INMA: Gipuzkoa: This study was funded by grants from Instituto de Salud Carlos III (FIS-PI09/00090, FIS-PI18/01142 including FEDER funds), CIBERESP, Dept of Health of the Basque Government (2013111089) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia and Beasain). Menorca: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; 97/0588; 00/0021-2, PI061756; PS0901958, PI14/00677 including FEDER funds), CIBERESP, Beca de la IV convocatoria de Ayudas a la Investigación en Enfemerdades Neurodegeneratives de La Caixa, and EC contract QLK4-CT-200-00263. Sabadell: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 including FEDER funds), Generalitat de Catalunya-CIRIT 1999SGR 00241 and Fundació La marató de TV3 (090430). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M. Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and cofunded by the European Social Fund “Investing in your future”. Valencia: This study was funded by grants from the European Union (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), Spain: Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041; FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/00663; Miguel Servet-FEDER CP11/00178, CP15/00025, CPII16/00051), Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, UGP-15-249), and Alicia Koplowitz Foundation 2017. Isle of Wight: This study was funded by grants from the National Institutes of Health USA (R01HL082925), Asthma UK (364), Isle of Wight NHS Trust and the British Medical Association. KOALA: The collection of data relevant for this study was funded by grants from the Netherlands Organisation for Health Research and Development (ZonMw; 2100.0090) and the Netherlands Asthma Foundation (3.2.03.48, 3.2.07.022). The researchers are independent from the funders. The funders had no role in the study design, data analysis, interpretation of data or writing of this report. We thank the children and parents for their participation in the KOALA study. LRC (Leicestershire Respiratory Cohorts): This study was funded by grants from the Swiss National Science Foundation (SNF: 320030-182628, 320030-162820, 3233-069348, 3200-069349) and Asthma UK 07/048. Lifeways Cross-Generation Cohort Study: This study was funded by the Health Research Board, Ireland, and the Irish Dept of Health and Children's Health Promotion Policy Unit. LISA: The LISA study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum München (former GSF), Helmholtz Centre for Environmental Research – UFZ, Leipzig, Research Institute at Marien-Hospital Bad Honnef for the first 2 years. The 4-, 6-, 10- and 15-year follow-up examinations of the LISA study were covered from the respective budgets of the involved partners (Helmholtz Zentrum München (former GSF), Helmholtz Centre for Environmental Research – UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF – Leibniz Research Institute for Environmental Medicine at the University of Düsseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296). Further, the 15-year follow-up examination of the LISA study was supported by the Commission of the European Communities, the Seventh Framework Program: MeDALL project. This project has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (949906). LucKi: LucKi is supported by Child and Youth Health Care Zuyderland, Public Health Service South Limburg and Maastricht University. We thank all parents and children for their participation in LucKi. LUKAS: This study was funded by research grants from the Academy of Finland (139021, 287675, 296814, 296817, 308254); Juho Vainio Foundation; EVO/VTR funding; Päivikki and Sakari Sohlberg Foundation; Farmers’ Social Insurance Institution (Mela); Finnish Cultural Foundation; Foundation for Pediatric Research; European Union QLK4-CT-2001-00250; and Finnish Institute for Health and Welfare, Finland. MAS-90: This study was funded by grants from the German Federal Ministry of Education and Research (MBMF; 07015633m 07ALE27, 01EE9405/5, 01EE9406) and the German Research Foundation (DFG; KE1462/2-1). Millennium Cohort Study: This study was funded by the Economic and Social Research Council and a consortium of UK government funders. We are grateful to the participating families and the Centre for Longitudinal Studies (CLS), UCL Institute of Education, for the use of these data and to the UK Data Service for making them available. However, neither CLS nor the UK Data Service bear any responsibility for the analysis or interpretation of these data. This work was supported by the Welcome Trust (187389/B/08/Z). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this ongoing cohort study. This research was supported by the Research Council of Norway through its Centres of Excellence funding scheme (262700). NINFEA: The authors are grateful to all the participants of the NINFEA cohort. The NINFEA study was partially funded by the Compagnia San Paolo Foundation. This research was partially funded by the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206). PELAGIE: We are grateful to the families who participated and continue to participate in the study. The cohort is supported by INSERM and received funding from the French National Research Agency, Fondation de France, French Agency for Food, Environmental and Occupational Health & Safety, National Institute for Public Health Surveillance (InVS), French Ministry of Labour, and French Ministry of Ecology. PIAMA: This study was funded by the Netherlands Organisation of Health Research and Development, Netherlands Organisation for Scientific Research, Netherlands Asthma Fund, Netherlands Ministry of Spatial Planning, Housing and the Environment, and Netherlands Ministry of Health, Welfare and Sport. REPRO_PL: This study was funded by the National Science Center Poland (DEC-2014/15/B/N27/00998). Rhea: This study was funded by the European Union Social Fund and the Hellenic Ministry of Health (“Program of prevention and early diagnosis of obesity and neurodevelopment disorders in preschool age children in the prefecture of Heraklion, Crete, Greece”; MIS 349580, NSRF 2007–2013). Additional funding from the National Institute of Environmental Health Sciences (NIEHS) supported L. Chatzi (R01ES030691, R01ES029944, R01ES030364, R21ES029681, R21ES028903, P30ES007048). STEPS: This study was funded by the University of Turku, Abo Akademi University, Turku University Hospital, Academy of Finland (123571, 140251, 277535) and Foundation for Pediatric Research Finland. SWS: This study was funded by the Medical Research Council, British Heart Foundation, Arthritis Research UK, Food Standards Agency, NIHR Southampton Biomedical Research Centre and the European Union's Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition (289346), and the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206). WHISTLER: The WHISTLER birth cohort was supported with a grant from the Netherlands Organisation for Health Research and Development (2001-1-1322) and by an unrestricted grant from GlaxoSmithKline Netherlands. GlaxoSmithKline had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the report for publication. WHISTLER-Cardio was supported with an unrestricted strategic grant from the University Medical Center Utrecht (UMCU).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits

  • Vogelezang, Suzanne
  • Vilor Tejedor, Natàlia, 1988-
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Sunyer Deu, Jordi
  • Felix, Janine Frédérique
The genetic background of childhood body mass index (BMI), and the extent to which the well-known associations of childhood BMI with adult diseases are explained by shared genetic factors, are largely unknown. We performed a genome-wide association study meta-analysis of BMI in 61,111 children aged between 2 and 10 years. Twenty-five independent loci reached genome-wide significance in the combined discovery and replication analyses. Two of these, located near NEDD4L and SLC45A3, have not previously been reported in relation to either childhood or adult BMI. Positive genetic correlations of childhood BMI with birth weight and adult BMI, waist-to-hip ratio, diastolic blood pressure and type 2 diabetes were detected (Rg ranging from 0.11 to 0.76, P-values <0.002). A negative genetic correlation of childhood BMI with age at menarche was observed. Our results suggest that the biological processes underlying childhood BMI largely, but not completely, overlap with those underlying adult BMI. The well-known observational associations of BMI in childhood with cardio-metabolic diseases in adulthood may reflect partial genetic overlap, but in light of previous evidence, it is also likely that they are explained through phenotypic continuity of BMI from childhood into adulthood., SFAG is supported by the Daniel B. Burke Chair for Diabetes Research and NIH Grant R01 HD058886. NVT is funded by a pre-doctoral grant from the Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 FI_B 00636), Generalitat de Catalunya – Fons Social Europeu. BK received personal funding from the European Research Council Advanced Grant META-GROWTH (ERC-2012-AdG – no. 322605). BF was supported by an Oak Foundation Fellowship. RMF and RNB are supported by Sir Henry Dale Fellowship (Wellcome Trust and Royal Society grant: WT104150). ATH is supported by a Wellcome Trust Senior Investigator award (grant number 098395/Z/12/Z). DM is supported by a Canada Research Chair. DLC was supported by the American Diabetes Association Grant 1-17-PDF-077. JTL was supported by the Finnish Cultural Foundation. DIB received a KNAW Academy Professor Award (PAH/6635). MH received PhD scholarship funding from TARGET (http://target.ku.dk), The Danish Diabetes Academy (http://danishdiabetesacademy.dk) and the Copenhagen Graduate School of Health and Medical Sciences. VWVJ received funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (ERC-2014-CoG-648916). ISF was supported by the European Research Council, Wellcome Trust (098497/Z/12/Z), Medical Research Council (MRC_MC_UU_12012/5), the NIHR Cambridge Biomedical Research Centre, the Botnar Foundation, the Bernard Wolfe Health Neuroscience Endowment and the European Community’s Seventh Framework Programme (FP7/2007-2013) project Beta-JUDO n°279153.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Prenatal exposure to nonpersistent chemical mixtures and fetal growth: a population-based study

  • Dries, Michiel A. van den
  • Keil, Alexander P.
  • Tiemeier, Henning
  • Pronk, Anjoeka
  • Spaan, Suzanne
  • Santos, Susana
  • Asimakopoulos, Alexandros G.
  • Kannan, Kurunthachalam
  • Gaillard, Romy
  • Guxens Junyent, Mònica
  • Trasande, Leonardo
  • Jaddoe, Vincent W. V.
  • Ferguson, Kelly K.
Background: Prenatal exposure to mixtures of nonpersistent chemicals is universal. Most studies examining these chemicals in association with fetal growth have been restricted to single exposure models, ignoring their potentially cumulative impact. Objective: We aimed to assess the association between prenatal exposure to a mixture of phthalates, bisphenols, and organophosphate (OP) pesticides and fetal measures of head circumference, femur length, and weight. Methods: Within the Generation R Study, a population-based cohort in Netherlands (n=776), urinary concentrations of 11 phthalate metabolites, 3 bisphenols, and 5 dialkylphosphate (DAP) metabolites were measured at <18, 18-25, and > 25 weeks of gestation and averaged. Ultrasound measures of head circumference, femur length, and estimated fetal weight (EFW) were taken at 18-25 and > 25 weeks of gestation, and measurements of head circumference, length, and weight were performed at delivery. We estimated the difference in each fetal measurement per quartile increase in all exposures within the mixture with quantile g-computation. Results: The average EFW at 18-25 wk and > 25 wk was 369 and 1,626g, respectively, and the average birth weight was 3,451g. Higher exposure was associated with smaller fetal and newborn growth parameters in a nonlinear fashion. At 18-25 wk, fetuses in the second, third, and fourth quartiles of exposure (Q2-Q4) had 26g [95% confidence intervals (CI): − 38, −13], 35g (95% CI:−55, −15), and 27g (95% CI: −54, 1) lower EFW compared with those in the first quartile (Q1). A similar dose-response pattern was observed at > 25wk, but all effect sizes were smaller, and no association was observed comparing Q4 to Q1. At birth, we observed no differences in weight between Q1-Q2 or Q1-Q3. However, fetuses in Q4 had 91g (95% CI: −258, 76) lower birth weight in comparison with those in Q1. Results observed at 18-25 and > 25wk were similar for femur length; however, no differences were observed at birth. No associations were observed for head circumference. Discussion: Higher exposure to a mixture of phthalates, bisphenols, and OP pesticides was associated with lower EFW in the midpregnancy period. In late pregnancy, these differences were similar but less pronounced. At birth, the only associations observed appeared when comparing individuals from Q1 and Q4. This finding suggests that even low levels of exposure may be sufficient to influence growth in early pregnancy, whereas higher levels may be necessary to affect birth weight. Joint exposure to nonpersistent chemicals may adversely impact fetal growth, and because these exposures are widespread, this impact could be substantial. https://doi.org/10.1289/EHP9178., This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) (ZIAES101575). It was additionally supported by grants from the NIH (RO1ES022972 and RO1ES029779) and NIEHS, NIH (HHSN273201500003C). H.T. was supported by the Netherlands Organization for Scientific Research (NWO) VICI grant (NWO-ZonMW: 016. VICI.170.200). M.G. is funded by a Miguel Servet fellowship (MS13/00054, CP18/00018) awarded by the Spanish Institute of Health Carlos III. We acknowledge support from the Spanish Ministry of Science and Innovation and the State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. The research leading to these results received funding from the European Union Horizon 2020 Research and Innovation Programme under Grant Agreement 733206 (LifeCycle), 874583 (ATHLETE) and 824989 (EUCAN-Connect). V.W.V.J. received grant ERC-2014-CoG-648916 from the European Research Council. R.G. received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002) and Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Maternal caffeine consumption during pregnancy and offspring cord blood DNA methylation: an epigenome-wide association study meta-analysis

  • Schellhas, Laura
  • Monasso, Giulietta S.
  • Felix, Janine Frédérique
  • Jaddoe, Vincent W. V.
  • Huang, Peiyuan
  • Fernández-Barrés, Sílvia
  • Vrijheid, Martine
  • Pesce, Giancarlo
  • Annesi-Maesano, Isabella
  • Page, Christian M.
  • Brantsaeter, Anne Lise
  • Bekkhus, Mona
  • Håberg, Siri E.
  • London, Stephanie J.
  • Munafò, Marcus R.
  • Zuccolo, Luisa
  • Sharp, Gemma C.
Background: Prenatal caffeine exposure may influence offspring health via DNA methylation, but no large studies have tested this. Materials & methods: Epigenome-wide association studies and differentially methylated regions in cord blood (450k or EPIC Illumina arrays) were meta-analyzed across six European cohorts (n = 3725). Differential methylation related to self-reported caffeine intake (mg/day) from coffee, tea and cola was compared with assess whether caffeine is driving effects. Results: One CpG site (cg19370043, PRRX1) was associated with caffeine and another (cg14591243, STAG1) with cola intake. A total of 12-22 differentially methylated regions were detected with limited overlap across caffeinated beverages. Conclusion: We found little evidence to support an intrauterine effect of caffeine on offspring DNA methylation. Statistical power limitations may have impacted our findings., This research was also conducted as part of the Childhood and Adolescence Psychopathology: Unravelling the Complex Etiology by a Large Interdisciplinary Collaboration in Europe) project, funded by the EU’s Horizon 2020 research and innovation program, Marie Sklodowska Curie Actions – MSCA-ITN-2016 – Innovative Training Networks under grant agreement no. 721567. GC Sharp is financially supported by an MRC New Investigator Research (grant code MR/S009310/1), an MRC project grant (MR/W020297/1) and the European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL, NutriPROGRAM project, UK MRC MR/S036520/1). BiB: BiB receives core funding from the Wellcome Trust (WT101597MA), the British Heart Foundation (CS/16/4/32482), a joint grant from the UK MRC and UK Economic and Social Science Research Council (MR/N024397/1) and the National Institute for Health Research under its Collaboration for Applied Health Research and Care for Yorkshire and Humber. The research presented in this paper, including obtaining genome-wide and epigenome-wide DNA methylation data is supported by the US NIH (R01 DK10324) and European Research Council (ERC) under the EU’s Seventh Framework Programme (FP7/2007-2013) ERC grant agreement no. 669545. Generation R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, Erasmus University Rotterdam, The Netherlands Organization for Health Research and Development and the Ministry of Health, Welfare and Sport. The EWAS data were funded by a grant to VW Jaddoe from The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research Netherlands Consortium for Healthy Aging (project no. 050-060-810), by funds from the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC and by a grant from the National Institute of Child and Human Development (R01HD068437). VW Jaddoe received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). This project received funding from the EU’s Horizon 2020 research and innovation program (733206, LifeCycle; 874739, LongITools; 874583, ATHLETE; 824989, EUCAN-Connect) and from the European JPI HDHL (NutriPROGRAM project, ZonMw The Netherlands no. 529051022 and PREcisE project ZonMw The Netherlands no. 529051023). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. MoBa 1 and 2 were supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01-ES-49019), NIH/National Institute of Environmental Health Sciences contract no. N01-ES-75558, the Norwegian Research Council/BIOBANK (grant no. 221097). This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project no. 262700. Where authors are identified as personnel of the International Agency for Research on Cancer/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/WHO. INMA: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041, PI041436, PI081151 incl. FEDER funds), Generalitat de Catalunya-CIRIT 1999SGR 00241, Fundació La marató de TV3 (090430), EU Commission (261357-MeDALL: Mechanisms of the Development of Allergy), European Research Council (268479-BREATHE: Brain Development and Air Pollution Ultrafine Particles in School Children) and the European JPI HDHL (and Instituto de Salud Carlos III) under the grant agreement no. AC18/00006 (NutriPROGRAM project). We acknowledge support from the Spanish Ministry of Science and Innovation and the State Research Agency through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the Research Centres of Catalonia Program. EDEN: Foundation for Medical Research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the EU FP7 programs (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (in collaboration with the French Association of Diabetic Patients [AFD]), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale complementary health insurance, French National Agency for Food Security, French Speaking Association for the Study of Diabetes and Metabolism (ALFEDIAM), Sao Paulo Research Foundation (FAPESP) grant no. 2012/51290-6, and EU-funded MeDALL project. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Ambient air pollution and childhood obesity from infancy to late childhood: An individual participant data meta-analysis of 10 European birth cohorts

  • Warkentin, Sarah
  • Fossati, Serena
  • Márquez, Sandra
  • Cadman, Tim
  • Casas Sanahuja, Maribel
  • Castro, Montserrat de
  • Guxens Junyent, Mònica
  • Nieuwenhuijsen, Mark J.
  • Vrijheid, Martine
Ambient air pollution may contribute to childhood obesity through various mechanisms. However, few longitudinal studies examined the relationship between pre- and postnatal exposure to air pollution and obesity outcomes in childhood. We aimed to investigate the association between pre- and postnatal exposure to air pollution and body mass index (BMI) and the risk of overweight/obesity throughout childhood in European cohorts. This study included mother-child pairs from 10 European birth cohorts (n = 37111 (prenatal), 33860 (postnatal)). Exposure to nitrogen dioxide (NO2) and fine particulate matter with aerodynamic diameter < 2.5 µm (PM2.5) was estimated at the home addresses during pre- and postnatal periods (year prior outcome assessment). BMI z-scores (continuous) and overweight/obesity status (categorical: zBMI≥+2 (<5 years) or ≥+1 (≥5 years) standard deviations) were derived at 0-2, 2-5, 5-9, 9-12 years. Associations between air pollution exposure and zBMI were estimated separately for each pollutant and cohort using linear and logistic longitudinal mixed effects models, followed by a random-effects meta-analysis. The overweight/obesity prevalence ranged from 12.3-40.5 % between cohorts at 0-2 years, 16.7-35.3 % at 2-5 years, 12.5-40.7 % at 5-9 years, and 10.7-43.8 % at 9-12 years. Results showed no robust associations between NO2 exposure and zBMI or overweight/obesity risk. Exposure to PM2.5 during pregnancy was associated with 23 % (95%CI 1.05;1.37) higher overweight/obesity risk across childhood, and higher zBMI and overweight/obesity risk at 9-12 years. Heterogeneity between cohorts was considerable (I2:25-89 %), with some cohort-specific associations; e.g., pre- and postnatal exposure to PM2.5 was associated with lower zBMI across age periods in UK cohorts (ALSPAC and BiB), while postnatal exposure to PM2.5 and NO2 was associated with higher zBMI in one Dutch cohort (Generation R). Overall, this large-scale meta-analysis suggests that prenatal PM2.5 exposure may be associated with adverse childhood obesity outcomes, but provides no evidence to support an effect of postnatal air pollution exposure, although cohort-specific associations were observed., The LifeCycle project received funding from the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 733,206 LifeCycle). This study was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874583 (ATHLETE project). ABCD: Core funding of the ABCD-study was provided by the Amsterdam University Medical center, Amsterdam, the Public Health Services, Amsterdam, and the Dutch Organization for Health Research and Development (ZonMw). ALSPAC: Core funding for the Avon Longitudinal Study of Parents and Children (ALSPAC) is provided by the UK Medical Research Council and Wellcome (217065/Z/19/Z) and the University of Bristol. A comprehensive list of grants funding is available on the ALSPAC website (https://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). BiB: Born in Bradford receives funding from by a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) [MR/N024391/1]; the British Heart Foundation [CS/16/4/32482]; a Wellcome Infrastructure Grant [WT101597MA]; the National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber [NIHR200166]; and was supported by UK Research and Innovation for the Healthy Urban Places consortium (grant reference MR/Y022785/1) as part of Population Health Improvement UK (PHI-UK), a national research network which works to transform health and reduce inequalities through change at the population level. The views expressed are those of the author(s), and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. DNBC: The Danish National Birth Cohort was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Health Foundation and other minor grants. The DNBC Biobank has been supported by the Novo Nordisk Foundation and the Lundbeck Foundation. Follow-up of mothers and children have been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B), the Lundbeck Foundation (195/04, R100-A9193), The Innovation Fund Denmark 0603-00294B (09-067124), the Nordea Foundation (02-2013-2014), Aarhus Ideas (AU R9-A959-13-S804), University of Copenhagen Strategic Grant (IFSV 2012), and the Danish Council for Independent Research (DFF – 4183-00594 and DFF − 4183-00152). EDEN: The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French speaking association for the study of diabetes and metabolism (ALFEDIAM). Gen R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. This project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583; LongITools, grant agreement No 874739). VJ received funding from a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). INMA: This study was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176) and the Generalitat de Catalunya-CIRIT (1999SGR 00241). INMA-Valencia was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5-1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), and Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249). INMA-Gipuzkoa was funded by grants from the Instituto de Salud Carlos III (FISFIS PI06/0867, FISPS09/0009) 0867, Red INMA G03/176) and the Departamento de Salud del Gobierno Vasco (2005111093 and 2009111069) and the Provincial Government of Guipúzcoa (DFG06/004 and FG08/001). INMA-Sabadell was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds; PI15/00118 incl. FEDER funds; CP16/00128 incl. FEDER funds; PI16/00118 incl. FEDER funds; PI16/00261 incl. FEDER funds; PI17/01340 incl. FEDER funds; PI18/00547 incl. FEDER funds), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securité Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010; EST-2016 RF-21), EU Commission (261357, 308333, 603,794 and 634453). Mònica Guxens was funded by a Miguel Servet II fellowship (CPII18/00018) awarded by the Spanish Institute of Health Carlos III. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/https://doi.org/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this on-going cohort study. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. This study includes data from the Norwegian Mother, Father and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. NINFEA: The NINFEA cohort was initially funded by the Compagnia SanPaolo Foundation and the Piedmont Region. It received funding from European projects: CHICOS (FP7 grant number HEALTH-FP7-2009-241604, LifeCycle (H2020 grant number 733206), ATHLETE (H2020 grant number 874583). RHEA: The “Rhea” project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 NV.2007.1.2.2.2. Project No 211,250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226,285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308,333 HELIX) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011-2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-15). SW acknowledges receiving the funding by the Generalitat de Catalunya (Agency for Management of University and Research Grants) with a Beatriu de Pinós post-doctoral fellowship (Ref: 2021 BP 00058). SS is supported by the European Uniońs Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie Postdoctoral Fellowship Grant Agreement No. 101,109,136 (URBANE). The funders had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cohort profile: Pregnancy and childhood epigenetics (PACE) consortium

  • Felix, Janine Frédérique
  • Kogevinas, Manolis
  • Sunyer Deu, Jordi
  • Vrijheid, Martine
  • London, Stephanie J.
V.W.J. received a grant from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and a Consolidator grant from the European Research Council (ERC-2014-CoG-648916) [...]. Main funding of the epigenetic studies in INMA were grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041), Spanish Ministry of Health (FIS-PI04/1436, FIS-PI08/1151 including FEDER funds, FIS-PI11/00610, FIS-FEDER-PI06/0867, FIS-FEDER-PI03-1615) Generalitat de Catalunya-CIRIT 1999SGR 00241, Fundació La Marató de TV3 (090430), EU Commission (261357-MeDALL: Mechanisms of the Development of ALLergy), and European Research Council (268479-BREATHE: BRain dEvelopment and Air polluTion ultrafine particles in scHool childrEn) [...].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania

  • Santos, Susana
  • Vrijheid, Martine
  • Jaddoe, Vincent W. V.
Background: Gestational weight gain differs according to pre-pregnancy body mass index and is related to the risks of adverse maternal and child health outcomes. Gestational weight gain charts for women in different pre-pregnancy body mass index groups enable identification of women and offspring at risk for adverse health outcomes. We aimed to construct gestational weight gain reference charts for underweight, normal weight, overweight, and grades 1, 2 and 3 obese women and to compare these charts with those obtained in women with uncomplicated term pregnancies. Methods: We used individual participant data from 218,216 pregnant women participating in 33 cohorts from Europe, North America, and Oceania. Of these women, 9065 (4.2%), 148,697 (68.1%), 42,678 (19.6%), 13,084 (6.0%), 3597 (1.6%), and 1095 (0.5%) were underweight, normal weight, overweight, and grades 1, 2, and 3 obese women, respectively. A total of 138, 517 women from 26 cohorts had pregnancies with no hypertensive or diabetic disorders and with term deliveries of appropriate for gestational age at birth infants. Gestational weight gain charts for underweight, normal weight, overweight, and grade 1, 2, and 3 obese women were derived by the Box-Cox t method using the generalized additive model for location, scale, and shape. Results: We observed that gestational weight gain strongly differed per maternal pre-pregnancy body mass index group. The median (interquartile range) gestational weight gain at 40 weeks was 14.2 kg (11.4-17.4) for underweight women, 14.5 kg (11.5-17.7) for normal weight women, 13.9 kg (10.1-17.9) for overweight women, and 11.2 kg (7.0-15.7), 8.7 kg (4.3-13.4) and 6.3 kg (1.9-11.1) for grades 1, 2, and 3 obese women, respectively. The rate of weight gain was lower in the first half than in the second half of pregnancy. No differences in the patterns of weight gain were observed between cohorts or countries. Similar weight gain patterns were observed in mothers without pregnancy complications. Conclusions: Gestational weight gain patterns are strongly related to pre-pregnancy body mass index. The derived charts can be used to assess gestational weight gain in etiological research and as a monitoring tool for weight gain during pregnancy in clinical practice., ALSPAC: The UK Medical Research Council and Wellcome (Grant ref.: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This study has received support from the US National Institute of Health (R01 DK10324) and European Research Council under the European Union’s Seventh Framework Programme (FP7/2007–2013)/ERC grant agreement no 669545. DA Lawlor works in a unit that receives UK MRC funding (MC_UU_12013/5) and is an NIHR senior investigator (NF-SI-0611-10196). Generation R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. Research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition under grant agreement no. 289346, the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 633595 (DynaHEALTH) and the European Union’s Horizon 2020 research and innovation programme under grant agreement 733206 (LifeCycle Project). Romy Gaillard received funding from the Dutch Heart Foundation (grant number 2017T013) and the Dutch Diabetes Foundation (grant number 2017.81.002). Vincent Jaddoe received grants from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (Consolidator Grant, ERC-2014-CoG-648916). HUMIS: European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreements Early Nutrition no. 289346 and by funds from the Norwegian Research Council’s MILPAAHEL programme, project no. 213148. INMA-Valencia: This study was funded by Grants from UE (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), and Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249).RHEA: The “Rhea” project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No. 211250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No. 226285 ENRIECO, EU-FP7-HEALTH-2012 Proposal No. 308333 HELIX) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion District, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–15). SWS: The SWS is supported by grants from the Medical Research Council, National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, and the European Union’s Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition (grant 289346). Study participants were drawn from a cohort study funded by the Medical Research Council and the Dunhill Medical Trust.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration

  • Liu, Xueping
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Feenstra, Bjarke
The duration of pregnancy is influenced by fetal and maternal genetic and non-genetic factors. Here we report a fetal genome-wide association meta-analysis of gestational duration, and early preterm, preterm, and postterm birth in 84,689 infants. One locus on chromosome 2q13 is associated with gestational duration; the association is replicated in 9,291 additional infants (combined P = 3.96 × 10-14). Analysis of 15,588 mother-child pairs shows that the association is driven by fetal rather than maternal genotype. Functional experiments show that the lead SNP, rs7594852, alters the binding of the HIC1 transcriptional repressor. Genes at the locus include several interleukin 1 family members with roles in pro-inflammatory pathways that are central to the process of parturition. Further understanding of the underlying mechanisms will be of great public health importance, since giving birth either before or after the window of term gestation is associated with increased morbidity and mortality., We are grateful for the cooperation of the EGG Consortium and the iPSYCH-BROAD Working Group. Lists of members of the EGG Consortium and collaborators in the iPSYCH-BROAD Working Group are given in the Supplementary Notes 1 and 2, respectively. For study-specific acknowledgements, please see Supplementary Note 3. B.F. received support from an Oak Foundation fellowship, a Novo Nordisk Foundation grant (12955), and a Bill and Melinda Gates Foundation subward (137097); X.L. received support from the Nordic Center of Excellence in Health-Related e-Sciences; D.H., V.A., A.J.S., R.N., T.M.W., and A.D.B. recieved funding from the Lundbeck Foundation (R102-A9118, R155-2014-1724, R248-2017-2003); L.S. reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899); R.M.F. is a Sir Henry Dale Fellow (Wellcome and Royal Society grant: WT104150); R.N.B. is funded by Wellcome and Royal Society (grant: WT104150); M.C.B. and D.A.L. work in a unit that receives UK MRC funding (MC_UU_00011/6); M.C.B. is supported by the MRC Skills Development Fellowship MR/P014054/1; D.A.L.’s contribution to this work was funded by grants from the US NIH and European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545; DevelopObese) and European Union’s Horizon 2020 research and innovation programme under grant agreement 733206 (LIFECYCLE); D.A.L. is also an NIHR senior investigator (NF-SI-0611-10,196); F.R. received partial funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.367); J.F.F. and V.W.V.J. received partial funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements 733206 (LIFECYCLE) and 633595 (DynaHEALTH); V.W.V.J. received partial funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (ERC Consolidator Grant, ERC-2014-CoG-648916); I.K. reports funding from Sigrid Juselius Foundation and Biomendicum Foundation postdoctoral fellowship; L.J.M. was supported by the March of Dimes Prematurity Research Center Ohio Collaborative, NICHD HD 091527, and the Bill and Melinda Gates Foundation (OPP1113966); M.T.W. was supported by NIH R01 NS099068, NIH R01 GM055479-19A1, a Lupus Research Alliance Novel Approaches award, CCRF Endowed Scholar, a CCHMC CpG Pilot study award, and a CCHMC Trustee award; K.K.R. received support from March of Dimes (21-FY13-19); C.P. was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre; M.I.M. is a Wellcome Senior Investigator and a NIHR Senior Investigator. His work is supported by Wellcome (090532, 093831, 203141, 106130) and by the NIH (U01DK105535). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. For study-specific funding, please see Supplementary Note 4.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Associations of green and blue space exposure in pregnancy with epigenetic gestational age acceleration

  • Marques, Irene
  • Santos, Susana
  • Monasso, Giulietta S.
  • Fossati, Serena
  • Vrijheid, Martine
  • Nieuwenhuijsen, Mark J.
  • Jaddoe, Vincent W. V.
  • Felix, Janine Frédérique
Early life is seen as a particularly sensitive period for environmental exposures. Natural space exposure during pregnancy has been associated with offspring health. Epigenetic gestational age acceleration, a discrepancy between clinical and DNA methylation-based gestational age, may underlie these associations. In 1359 mother-newborn pairs from the population-based Generation R Study, we examined the associations of natural space exposure, defined as surrounding greenness, distance to major green and blue (water) space, and size of the blue space during pregnancy with offspring epigenetic gestational age acceleration. Natural space exposure was based on participants’ geocoded addresses, and epigenetic gestational age acceleration was calculated from cord blood DNA methylation using Bohlin’s and Knight’s epigenetic clocks. Sensitivity analyses were conducted in a subgroup of newborns with optimal pregnancy dating, based on last menstrual period. Surrounding greenness, measured in normalized difference vegetation index values, was intermediate (median 0.4, IQR 0.2), and 84% and 56% of the participants had a major green or blue space near their home address, respectively. We did not observe associations of natural space availability during pregnancy with offspring epigenetic gestational age acceleration. This could imply that epigenetic gestational age acceleration in cord blood does not underlie the effects of residential natural space availability in pregnancy on offspring health. Future studies could investigate whether residential natural space availability during pregnancy is associated with offspring differential DNA methylation at other CpGs than those included in the epigenetic gestational clocks., The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Netherlands Organization for Scientific Research (NWO), the Ministry of Health, Welfare and Sport, and the Ministry of Youth and Families. The EWAS data was funded by a grant to VWVJ from the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA; project number 050-060-810), by funds from the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam (R01HD068437). VWVJ received funding from the European Research Council (ERC-2014-CoG-648916). The project was supported by funding from the European Union’s Horizon 2020 research and innovation program under grant agreements No 733206 (LifeCycle), 874739 (LongITools) and 874583 (ATHLETE), and from the European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL, NutriPROGRAM project, ZonMw the Netherlands no. 529051022 and PREcisE project ZonMw the Netherlands no. 529051023).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI

  • Couto Alves, Alexessander
  • Estivill, Xavier, 1955-
  • Sunyer Deu, Jordi
  • Early Growth Genetics (EGG) Consortium
Early childhood growth patterns are associated with adult health, yet the genetic factors and the developmental stages involved are not fully understood. Here, we combine genome-wide association studies with modeling of longitudinal growth traits to study the genetics of infant and child growth, followed by functional, pathway, genetic correlation, risk score, and colocalization analyses to determine how developmental timings, molecular pathways, and genetic determinants of these traits overlap with those of adult health. We found a robust overlap between the genetics of child and adult body mass index (BMI), with variants associated with adult BMI acting as early as 4 to 6 years old. However, we demonstrated a completely distinct genetic makeup for peak BMI during infancy, influenced by variation at the LEPR/LEPROT locus. These findings suggest that different genetic factors control infant and child BMI. In light of the obesity epidemic, these findings are important to inform the timing and targets of prevention strategies., All the authors acknowledge the following sponsors for support: UK Medical Research Council and Wellcome Trust (grant reference 102215/2/13/2); NIH grant R01 HD056465; Danish National Research Foundation; NIH Genes, Environment and Health Initiative (GEI; U01HG004423); NIH GEI (U01HG004438); Lundbeck Foundation (R19-A2059); Danish Medical Research Council (09-065592); French Ministry of Research; INSERM; South West NHS Research and Development; Exeter NHS Research and Development; Netherlands Organization for Health Research and Development (VIDI 016. 136. 361); European Union’s Horizon 2020 research and innovation programme under grant agreement nos. 633595 (DynaHEALTH), 733206 (LIFECYCLE), and 721567 (CAPICE); European Research Council (ERC consolidator grant, ERC-2014-CoG-648916); Academy of Finland (project grants 209072 and 129255); British Heart Foundation and Academy of Finland (grants 134839 and 129287); National Public Health Institute, Helsinki, Finland; World Cancer Research Fund (WCRF UK) and World Cancer Research Fund International (2017/1641); Wellcome Trust (WT205915); European Commission under the Marie Curie Intra-European Fellowship (project MARVEL, PIEF-GA-2013-626461); Instituto de Salud Carlos III (CB06/02/0041, FIS PI041436, PI081151, PI041705, and PS09/00432 and FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, and 09/02647); Spanish Ministry of Science and Innovation (SAF2008-00357); European Commission (ENGAGE project and grant agreement HEALTH-F4-2007-201413); Fundació La Marató de TV3; Generalitat de Catalunya-CIRIT 1999SGR 00241; Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296); National Health and Medical Research Council of Australia (grant IDs 403981 and 003209); Canadian Institutes of Health Research (grant ID MOP-82893); Royal Society of New Zealand Marsden Fund (grant 16-UOO-072); Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics, and SALVE); University Hospital Oulu; Biocenter; University of Oulu, Finland (75617); European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); NIH/NIMH (5R01MH63706:02); Medical Research Council, United Kingdom (G0500539 and G0600705, PrevMetSyn/SALVE, MR/M013138, G0802782); Wellcome Trust (project grant GR069224); and EU Framework Programme 7 EurHEALTHAgeing 277849. This research was conducted using the UK Biobank Resource.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Association of gestational weight gain with adverse maternal and infant outcomes

  • LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group
Importance: Both low and high gestational weight gain have been associated with adverse maternal and infant outcomes, but optimal gestational weight gain remains uncertain and not well defined for all prepregnancy weight ranges. Objectives: To examine the association of ranges of gestational weight gain with risk of adverse maternal and infant outcomes and estimate optimal gestational weight gain ranges across prepregnancy body mass index categories. Design, setting, and participants: Individual participant-level meta-analysis using data from 196 670 participants within 25 cohort studies from Europe and North America (main study sample). Optimal gestational weight gain ranges were estimated for each prepregnancy body mass index (BMI) category by selecting the range of gestational weight gain that was associated with lower risk for any adverse outcome. Individual participant-level data from 3505 participants within 4 separate hospital-based cohorts were used as a validation sample. Data were collected between 1989 and 2015. The final date of follow-up was December 2015. Exposures: Gestational weight gain. Main outcomes and measures: The main outcome termed any adverse outcome was defined as the presence of 1 or more of the following outcomes: preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, and small or large size for gestational age at birth. Results: Of the 196 670 women (median age, 30.0 years [quartile 1 and 3, 27.0 and 33.0 years] and 40 937 were white) included in the main sample, 7809 (4.0%) were categorized at baseline as underweight (BMI <18.5); 133 788 (68.0%), normal weight (BMI, 18.5-24.9); 38 828 (19.7%), overweight (BMI, 25.0-29.9); 11 992 (6.1%), obesity grade 1 (BMI, 30.0-34.9); 3284 (1.7%), obesity grade 2 (BMI, 35.0-39.9); and 969 (0.5%), obesity grade 3 (BMI, ≥40.0). Overall, any adverse outcome occurred in 37.2% (n = 73 161) of women, ranging from 34.7% (2706 of 7809) among women categorized as underweight to 61.1% (592 of 969) among women categorized as obesity grade 3. Optimal gestational weight gain ranges were 14.0 kg to less than 16.0 kg for women categorized as underweight; 10.0 kg to less than 18.0 kg for normal weight; 2.0 kg to less than 16.0 kg for overweight; 2.0 kg to less than 6.0 kg for obesity grade 1; weight loss or gain of 0 kg to less than 4.0 kg for obesity grade 2; and weight gain of 0 kg to less than 6.0 kg for obesity grade 3. These gestational weight gain ranges were associated with low to moderate discrimination between those with and those without adverse outcomes (range for area under the receiver operating characteristic curve, 0.55-0.76). Results for discriminative performance in the validation sample were similar to the corresponding results in the main study sample (range for area under the receiver operating characteristic curve, 0.51-0.79). Conclusions and relevance: In this meta-analysis of pooled individual participant data from 25 cohort studies, the risk for adverse maternal and infant outcomes varied by gestational weight gain and across the range of prepregnancy weights. The estimates of optimal gestational weight gain may inform prenatal counseling; however, the optimal gestational weight gain ranges had limited predictive value for the outcomes assessed., Avon Longitudinal Study of Parents and Children (ALSPAC): Funded by grant 102215/2/13/2 from the UK Medical Research Council and Wellcome, core support from the University of Bristol, grant R01 DK10324 from the US National Institutes of Health, grant agreement 669545 from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013), award MC_UU_12013/5 from the UK Medical Research Council, and Dr Lawlor is a National Institute for Health Research senior investigator (NF-SI-0611-10196). Cohort of Newborns in Emilia Romagna (CoNER): No funding reported. Danish National Birth Cohort (DNBC): The Danish Epidemiology Science Centre initiated and created the DNBC and this center was established by the Danish National Research Foundation via a major grant. Additional support was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The 7-year follow-up study was supported by award 195/04 from the Lundbeck Foundation and award SSVF 0646 from the Danish Medical Research Council. Étude des Déterminants pré et postnatals du développement et de la santé de l’ENfant (EDEN): Supported by the French foundation for medical research, the French national agency for research, the French national institute for research in public health (IRESP: TGIR cohorte santé 2008 program), the French ministry of health, the French ministry of research, the INSERM bone and joint diseases national research and human nutrition national research programs, Paris-Sud University, Nestlé, the French national institute for population health surveillance, the French national institute for health education, the European Union FP7 programs (2007-2013; HELIX, ESCAPE, ENRIECO, and Medall projects), the French diabetes national research program through a collaboration with the French association of diabetic patients, the French agency for environmental health safety (now ANSES), the Mutuelle Générale de l’Education Nationale (a complementary health insurance), the French national agency for food security, and the French-speaking association for the study of diabetes and metabolism. Family and Children of Ukraine (FCOU): Supported by the Fogarty International Center at the US National Institutes of Health, the US National Institute of Environmental Health Sciences, the US Centers for Disease Control and Prevention, the US Environmental Protection Agency, and the National Academy of Medical Sciences of Ukraine. Genetica e Ambiente: Studio Prospettico dell’Infanzia in Italia (GASPII): Supported by the Italian ministry of health. Groningen Expert Center for Kids with Obesity (GECKO Drenthe): Supported by an unrestricted grant from Hutchison Whampoa Ltd and funding from the University of Groningen, Well Baby Clinic Foundation Icare, Noordlease, the Paediatric Association of the Netherlands, and Youth Health Care Drenthe. Genetics of Glucose regulation in Gestation and Growth (Gen3G): Supported by operating grant 20697 from the Fonds de recherche du Québec en santé, operating grant MOP 115071 from the Canadian Institute of Health Reseach, a grant from Diabète Québec, and operating grant OG-3-08-2622-JA from the Canadian Diabetes Association. Generation R: The general design of the study received financial support from Erasmus MC, University Medical Center Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development, the Netherlands Organisation for Scientific Research and the Ministry of Health, Welfare, and Sport, and the Ministry of Youth and Families. The research leading to these results received funding from the European Union Horizon 2020 Research and Innovation Programme under grant 733206 (LifeCycle Project). Dr Jaddoe received grant ERC-2014-CoG-648916 from the European Research Council. Dr Gaillard received grant 2017T013 from the Dutch Heart Foundation, grant 2017.81.002 from the Dutch Diabetes Foundation, and grant 543003109 from the Netherlands Organisation for Health Research and Development. Generation XXI: Funded by Programa Operacional de Saúde–Saúde XXI, Quadro Comunitário de Apoio III and Administração Regional de Saúde Norte (Regional Department of Ministry of Health), by POCI-01-0145-FEDER-016837 through the Operational Programme Competitiveness and Internationalization and national funding from the Foundation for Science and Technology (Portuguese Ministry of Science, Technology, and Higher Education) under the project PathMOB, by FCT PTDC/DTP-EPI/3306/2014 (Risco cardiometabólico na infância: desde o início da vida ao fim da infância), by POCI-01-0145-FEDER-006862 and UID/DTP/04750/2013 (Unidade de Investigação em Epidemiologia-Instituto de Saúde Pública da Universidade do Porto), and FCT investigator contract IF/01060/2015 awarded to Dr A. C. Santos. Growth, Exercise and Nutrition Epidemiological Study In preSchoolers (GENESIS): Supported by a research grant from Friesland Hellas. German Infant Nutritional Intervention plus environmental and genetic influences (GINIplus): Supported for the first 3 years by the Federal Ministry for Education, Science, Research, and Technology (intervention group) and Helmholtz Zentrum Munich (observation group). The 4-, 6-, 10-, and 15-year follow-up examinations were covered from the respective budgets of the 5 study centers (Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, LMU Munich, TU Munich, IUF-Leibniz Research-Institute for Environmental Medicine at the University of Düsseldorf) and by funding from the European Commission 7th Framework Programme (MeDALL project), Mead Johnson, and Nestlé and grant FKZ 20462296 from the Federal Ministry for Environment (awarded to IUF Düsseldorf). Norwegian Human Milk Study (HUMIS): Funded by award FP7/2007-2013 from the European Commission 7th Framework Programme, grant 289346 from European Union EarlyNutrition project, and by funds for project 213148 from the Norwegian Research Council’s MILPAAHEL programme. INfancia y Medio Ambiente (INMA)-Sabadell: Funded by grant Red INMA G03/176 from the Instituto de Salud Carlos III in Spain and grant 1999SGR 00241 from the Generalitat de Catalunya-CIRIT. INMA-Valencia: Funded by grants FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1 from the European Commission, grants G03/176, FIS-FEDER PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, Miguel Servet FEDER CP11/00178, CP15/00025, and CPII16/00051 from the Instituto de Salud Carlos III in Spain, and grants UGP 15-230, UGP-15-244, and UGP-15-249 from the Generalitat Valenciana, Foundation for the Promotion of Health and Biomedical Research of Valencia Region. INMA-Gipuzkoa: Funded by grants FISFIS PI06/0867, FIS-PS09/0009 0867, and Red INMA G03/176 from the Instituto de Salud Carlos III in Spain, grants 2005111093 and 2009111069 from the Departamento de Salud del Gobierno Vasco, and grants DFG06/004 and FG08/001 from the Provincial Government of Guipúzcoa. INMA-Menorca: This study was funded by grant Red INMA G03/176 from the Instituto de Salud Carlos III in Spain. Child, parents and health: lifestyle and genetic constitution (KOALA): Data collection from pregnancy up to the age of 1 year was supported by grants from Royal Friesland Foods, the Triodos Foundation, the Phoenix Foundation, the Raphaël Foundation, the Iona Foundation, the Foundation for the Advancement of Heilpedagogie, the Netherlands Organisation for Health Research and Development (2100.0090), the Netherlands Asthma Foundation (3.2.03.48 and 3.2.07.022), and the Netherlands Heart Foundation (2008B112). Krakow Cohort: Funded by grants R01ES010165 and R01ES015282 from the US National Institute of Environmental Health Sciences and by funding from the Lundin Foundation, the John and Wendy Neu Family Foundation, the Gladys and Roland Harriman Foundation, and the Anonymous Foundation. Influences of Lifestyle-Related Factors on the Immune System and the Development of Allergies in Childhood plus the influence of traffic emissions and genetics (LISAplus): Mainly supported by grants for the first 2 years from the Federal Ministry for Education, Science, Research, and Technology, the Helmholtz Zentrum Munich, the Helmholtz Centre for Environmental Research-UFZ, the Research Institute at Marien-Hospital Wesel, and a pediatric practice in Bad Honnef. The 4-, 6-, 10-, and 15-year follow-up examinations were funded by the respective budgets of the involved partners (the Helmholtz Zentrum Munich, the Helmholtz Centre for Environmental Research-UFZ, the Research Institute at Marien-Hospital Wesel, a pediatric practice in Bad Honnef, and the IUF–Leibniz-Research Institute for Environmental Medicine at the University of Düsseldorf), by grant FKZ 20462296 from the Federal Ministry for Environment (awarded to IUF Düsseldorf), and by support from the European Commission 7th Framework Programme (MeDALL project). LUKAS Cohort: Funded by EVO/VTR grants, grants 139021 and 287675 from the Academy of Finland, grant QLK4-CT-2001-00250 from the European Union, and funding from the Juho Vainio Foundation, the Foundation for Pediatric Research, the Päivikki and Sakari Sohlberg Foundation, the Finnish Cultural Foundation, and the National Institute for Health and Welfare in Finland. Norwegian Mother and Child Cohort Study (MoBa): Supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, contract N01-ES-75558 with the US National Institute of Environmental Health Sciences, and grants UO1 NS 047537-01 and UO1 NS 047537-06A1 from the US National Institute of Neurological Disorders and Stroke. Nascita e INFanzia: gli Effetti dell’Ambiente (NINFEA): Partially funded by the Compagnia San Paolo Foundation and by the Piedmont Region. Prevention and Incidence of Asthma and Mite Allergy (PIAMA): Supported by the Organization for Health Research and Development, the Organization for Scientific Research, the Asthma Fund, the Ministry of Spatial Planning, Housing, and the Environment, and the Ministry of Health, Welfare, and Sport (all organizations in the Netherlands). Piccolipiù Project: Financially supported by CCM grants during 2010 and 2014 from the Italian National Center for Disease Prevention and Control and funding (art 12 and 12 bis D.lgs 502/92) from the Italian Ministry of Health. PRegnancy and Infant DEvelopment (PRIDE Study): Supported by grants from the Netherlands Organization for Health Research and Development, the Radboud Institute for Health Sciences, and the Lung Foundation Netherlands. Project Viva: Funded by grants R01 HD034568 and UG3OD023286 from the US National Institutes of Health. Polish Mother and Child Cohort Study (REPRO_PL): Funded by grants DEC-2014/15/B/NZ7/00998 and FP7 HEALS 603946 from the National Science Centre in Poland and grant 3068/7.PR/2014/2 from the Polish Ministry of Science and Higher Education. Exposure of Preschool-Age Greek Children (RHEA): Financially supported by European Commission projects FP6-2003-Food-3-NewGeneris, FP6-STREP Hiwate, FP7-ENV.2007.1.2.2.2, FP7-2008-ENV-1.2.1.4 Envirogenomarkers, FP7-HEALTH-2009-single stage CHICOS, FP7-ENV.2008.1.2.1.6, FP7-HEALTH-2012, and 211250-Escape and proposals 226285 ENRIECO and 308333 HELIX and by the Greek Ministry of Health. Slovak PCB Study: Support was provided by grants R01 CA096525, R03 TW007152, P30 ES001247, P30 ES023513, and K12 ES019852 from the US National Institutes of Health. STEPS: This study was supported by the University of Turku, Abo Akademi University, the Turku University Hospital, the City of Turku, the Juho Vainio Foundation, and the Yrjö Jahnsson Foundation and by grants 121569 and 123571 from the Academy of Finland. Southampton Women’s Survey (SWS): Supported by funding from the Medical Research Council, the National Institute for Health Research Southampton Biomedical Research Centre, the University of Southampton, Dunhill Medical Trust, and the University Hospital Southampton National Health Service Foundation Trust, FP7/2007-2013 from the European Commission 7th Framework Programme, and grant 289346 from the European Union EarlyNutrition project.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gestational organophosphate pesticide exposure and childhood cardiovascular outcomes

  • Stevens, Danielle R.
  • Blaauwendraad, Sophia M.
  • Bommarito, Paige A.
  • van den Dries, Michiel
  • Trasande, Leonardo
  • Spaan, Suzanne
  • Pronk, Anjoeka
  • Tiemeier, Henning
  • Gaillard, Romy
  • Jaddoe, Vincent W. V.
  • Ferguson, Kelly K.
Introduction: The general population is chronically exposed to organophosphate pesticides through various routes including ingestion, hand-to-mouth contact, inhalation, and dermal contact. Exposure to organophosphate pesticides during pregnancy impairs fetal development, but the potential long-term effects of gestational organophosphate pesticide exposure are less well understood. Methods: We investigated associations between gestational organophosphate pesticide exposure and cardiovascular outcomes in 643 children in the Generation R Study, a prospective pregnancy cohort based in Rotterdam, The Netherlands. Urinary organophosphate pesticide metabolites (dimethyl [∑DMAP], diethyl [∑DEAP], and total dialkyl phosphate [∑DAP] metabolites) were quantified in three urine samples collected from pregnant participants, and their children were followed until age 10 years at which time cardiac magnetic resonance imaging, ultrasonography, blood pressure, and serum biomarkers assessed cardiovascular health. Linear regression models estimated associations (β and 95 % confidence interval [CI]) between a one-interquartile range (IQR) increase in averaged gestational exposure biomarker concentrations and z-scored pediatric cardiovascular outcomes. We investigated effect modification of associations by PON1 genotype. Results: Carotid intima-media thickness z-score was lower (β: -0.14 [95 % CI: -0.25, -0.02]) and HDL cholesterol z-score was higher (β: 0.14 [95 % CI: 0.02, 0.25]) for increases in ∑DEAP concentrations. Carotid intima-media distensibility z-score was lower (β: -0.08 [95 % CI: -0.19, 0.03]) for increases in ∑DMAP concentrations, and systolic blood pressure z-score was higher (β: 0.10 [95 % CI: -0.01, 0.21]) for increases in ∑DMAP and ∑DAP. Among those with PON1-161CC and PON1-L55MTT genotypes, higher organophosphate pesticide concentrations conferred an excess risk of adverse vascular and glycemic outcomes, respectively. Conclusions: We observed heterogenous associations between gestational organophosphate pesticide exposure and pediatric cardiovascular health: an anti-atherogenic profile was observed for increases in ∑DEAP concentrations, and impairments in multiple aspects of cardiovascular health was observed for increases in ∑DMAP concentrations. PON1-161 and PON1-L55M single nucleotide polymorphisms modified associations for vascular and glycemic outcomes, respectively., This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) (ZIAES101575) and a research and development contract (HHSN273201500003C). The Generation R Study is financially supported by the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. DRS received a grant from the NIEHS through award number 1K99ES035107-01. VWVJ received a grant from the Netherlands Organization for Health Research and Development (NWO, ZonMw-VIDI 016.136.361) and a European Research Council Consolidator Grant (ERC-2014-CoG-648916). H.T. was supported by the Netherlands Organization for Scientific Research (NWO) VICI grant (NWO-ZonMW: 016. VICI.170.200). RG received funding from the Dutch Diabetes Foundation (grant number 2017.81.002), the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109, NWO, ZonMw 09150172110034) and from the European Union’s Horizon 2020 research and innovation program under the ERA-NET Cofund action (no 727565), EndObesity, ZonMW the Netherlands (no. 529051026). LT was supported by NIEHS grants (R01ES022972 and R01ES029779). This project has additionally received funding from the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL), EndObesity, ZonMW Netherlands (No. 529051026). Furthermore, this work was supported by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 733,206 (LifeCycle), 874,583 (ATHLETE) and 824,989 (EUCAN-Connect), the Spanish Ministry of Science and Innovation and the State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and the Generalitat de Catalunya through the CERCA Program.
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Novel Loci for Childhood Body Mass Index and Shared Heritability with Adult Cardiometabolic Traits

  • Vogelezang, Suzanne
  • Bradfield, Jonathan P.
  • Ahluwalia, Tarunveer S.
  • Curtin, John A.
  • Lakka, Timo A.
  • Grarup, Niels
  • Scholz, Markus
  • Van der Most, Peter J.
  • Monnereau, Claire
  • Stergiakouli, Evie
  • Heiskala, Anni
  • Horikoshi, Momoko
  • Fedko, Iryna O.
  • Vilor Tejedor, Natalia
  • Cousminer, Diana L.
  • Standl, Marie
  • Wang, Carol A.
  • Viikari, Jorma
  • Geller, Frank
  • Iñiguez, Carmen
  • Pitkanen, Niina
  • Chesi, Alessandra
  • Bacelis, Jonas
  • Yengo, Loic
  • Torrent, Maties
  • Ntalla, Ioanna
  • Helgeland, Oyvind
  • Selzam, Saskia
  • Vonk, Judith M.
  • Zafarmand, Mohammed H.
  • Heude, Barbara
  • Farooqi, Ismaa Sadaf
  • Alyass, Akram
  • Beaumont, Robin N.
  • Have, Christian T.
  • Rzehak, Peter
  • Bilbao Catalá, José Ramón
  • Schnurr, Theresia M.
  • Barroso, Ines
  • Bonnelykke, Klaus
  • Beilin, Lawrence J.
  • Carstensen, Lisbeth
  • Charles, Marie Aline
  • Chawes, Bo
  • Clement, Karine
  • Closa Monasterolo, Ricardo
  • Custovic, Adnan
  • Eriksson, Johan G.
  • Escribano, Joaquín
  • Groen-Blokhuis, Maria
  • Grote, Veit
  • Gruszfeld, Dariusz
  • Hakonarson, Hakon
  • Hansen, Torben
  • Hattersley, Andrew T.
  • Hollensted, Mette
  • Hottenga, Jouke Jan
  • Hypponen, Elina
  • Johansson, Stefan
  • Joro, Raimo
  • Kahonen, Mika
  • Karhunen, Ville
  • Kiess, Wieland
  • Knight, Bridget A.
  • Koletzko, Berthold
  • Kuehnapfel, Andreas
  • Landgraf, Kathrin
  • Langhendries, Jean-Paul
  • Lehtimaki, Terho
  • Leinonen, Jaakko T.
  • Li, Aihuali
  • Lindi, Virpi
  • Lowry, Estelle
  • Bustamante, Mariona
  • Medina Gómez, Carolina
  • Melbye, Mads
  • Michaelsen, Kim F.
  • Morgen, Camilla S.
  • Mori, Trevor A.
  • Nielsen, Tenna R. H.
  • Niinikoski, Harri
  • Oldehinkel, Albertine J.
  • Pahkala, Katja
  • Panoutsopoulou, Kalliope
  • Pedersen, Oluf
  • Pennell, Craig E.
  • Power, Christine
  • Reijneveld, Sijmen A.
  • Rivadeneira, Fernando
  • Simpson, Angela
  • Sly, Peter D.
  • Stokholm, Jakob
  • Teo, Kook K.
  • Thiering, Elisabeth
  • Timpson, Nicholas J.
  • Uitterlinden, Andre G.
  • Van Beijsterveldt, Catharina E. M.
  • Van Schaik, Barbera D. C.
  • Vaudel, Marc
  • Verduci, Elvira
  • Vinding, Rebecca K.
  • Vogel, Mandy
  • Zeggini, Eleftheria
  • Sebert, Sylvain
  • Lind, Mads V.
  • Brown, Christopher D.
  • Santa Marina, Loreto
  • Reischl, Eva
  • Frithioff-Bojsoe, Christine
  • Meyre, David
  • Wheeler, Eleanor
  • Ong, Ken
  • Nohr, Ellen A.
  • Vrijkotte, Tanja G. M.
  • Koppelman, Gerard H.
  • Plomin, Robert
  • Njolstad, Pal R.
  • Dedoussis, George D.
  • Froguel, Philippe
  • Sorensen, Thorkild I. A.
  • Jacobsson, Bo
  • Freathy, Rachel M.
  • Zemel, Babette S.
  • Raitakari, Olli
  • Vrijheid, Martine
  • Feenstra, Bjarke
  • Lyytikainen, Leo-Pekka
  • Snieder, Harold
  • Kirsten, Holger
  • Holt, Patrick G.
  • Heinrich, Joachim
  • Widen, Elisabeth
  • Sunyer, Jordi
  • Boomsma, Dorret I.
  • Jarvelin, Marjo-Riitta
  • Koerner, Antje
  • Smith, George Davey
  • Holm, Jens-Christian
  • Atalay, Mustafa
  • Murray, Clare
  • Bisgaard, Hans
  • McCarthy, Mark I.
  • Jaddoe, Vincent W. V.
  • Grant, Struan F. A.
  • Felix, Janine F.
The genetic background of childhood body mass index (BMI), and the extent to which the well-known associations of childhood BMI with adult diseases are explained by shared genetic factors, are largely unknown. We performed a genome-wide association study meta-analysis of BMI in 61,111 children aged between 2 and 10 years. Twenty-five independent loci reached genome-wide significance in the combined discovery and replication analyses. Two of these, located nearNEDD4LandSLC45A3, have not previously been reported in relation to either childhood or adult BMI. Positive genetic correlations of childhood BMI with birth weight and adult BMI, waist-to-hip ratio, diastolic blood pressure and type 2 diabetes were detected (R(g)ranging from 0.11 to 0.76, P-values <0.002). A negative genetic correlation of childhood BMI with age at menarche was observed. Our results suggest that the biological processes underlying childhood BMI largely, but not completely, overlap with those underlying adult BMI. The well-known observational associations of BMI in childhood with cardio-metabolic diseases in adulthood may reflect partial genetic overlap, but in light of previous evidence, it is also likely that they are explained through phenotypic continuity of BMI from childhood into adulthood. Author summary Although twin studies have shown that body mass index (BMI) is highly heritable, many common genetic variants involved in the development of BMI have not yet been identified, especially in children. We studied associations of more than 40 million genetic variants with childhood BMI in 61,111 children aged between 2 and 10 years. We identified 25 genetic variants that were associated with childhood BMI. Two of these have not been implicated for BMI previously, located close to the genesNEDD4LandSLC45A3. We also show that the genetic background of childhood BMI overlaps with that of birth weight, adult BMI, waist-to-hip-ratio, diastolic blood pressure, type 2 diabetes, and age at menarche. Our results suggest that the biological processes underlying childhood BMI largely overlap with those underlying adult BMI. However, the overlap is not complete. Additionally, the genetic backgrounds of childhood BMI and other cardio-metabolic phenotypes are overlapping. This may mean that the associations of childhood BMI and later cardio-metabolic outcomes are partially explained by shared genetics, but it could also be explained by the strong association of childhood BMI with adult BMI., CP received funding from the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. MMcC is a Wellcome Senior Investigator and an NIHR Senior Investigator. MMcC received funding from Wellcome (090532, 106130, 098381, 203141, 212259), NIDDK (U01DK105535), and NIHR (NF-SI-0617-10090). TGMV was supported by ZonMW (TOP 40-00812-9811010). DLC was supported by the American Diabetes Association Grant 1-17-PDF-077. SFAG is supported by the Daniel B. Burke Chair for Diabetes Research and NIH Grant R01 HD058886. NVT is funded by a pre-doctoral grant from the Agencia de Gestio d'Ajuts Universitaris i de Recerca (2017 FI_B 00636), Generalitat de Catalunya -Fons Social Europeu. BK received personal funding from the European Research Council Advanced Grant META-GROWTH (ERC-2012-AdG -no. 322605). BF was supported by an Oak Foundation Fellowship. RMF and RNB are supported by Sir Henry Dale Fellowship (Wellcome Trust and Royal Society grant: WT104150). ATH is supported by a Wellcome Trust Senior Investigator award (grant number 098395/Z/12/Z). DM is supported by a Canada Research Chair. DLC was supported by the American Diabetes Association Grant 1-17-PDF077. JTL was supported by the Finnish Cultural Foundation. DIB received a KNAW Academy Professor Award (PAH/6635). MH received PhD scholarship funding from TARGET (http://target.ku.dk), The Danish Diabetes Academy (http://danishdiabetesacademy.dk) and the Copenhagen Graduate School of Health and Medical Sciences. VWVJ received funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (ERC-2014-CoG-648916). ISF was supported by the European Research Council, Wellcome Trust (098497/Z/12/Z), Medical Research Council (MRC_MC_UU_12012/5), the NIHR Cambridge Biomedical Research Centre, the Botnar Foundation, the Bernard Wolfe Health Neuroscience Endowment and the European Community's Seventh Framework Programme (FP7/2007-2013) project Beta-JUDO n degrees 279153. IB acknowledges funding from Wellcome (WT206194). ES works in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1, MC_UU_00011/3). GDS works in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_00011/1). KC received funds from the French National Agency of Research, F-CRIN/FORCE. All funding for the studies that provided the underlying data for this manuscript can be found in S1 Text. The funders had no role in study design, data collection and analysis, data interpretation, decision to publish, or preparation of the manuscript. Editorial
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: findings from the pregnancy and childhood epigenetics (PACE) consortium

  • Sharp, Gemma C.
  • Salas, Lucas A.
  • Monnereau, Claire
  • Allard, Catherine
  • Yousefi, Paul
  • Everson, Todd M.
  • Bohlin, Jon
  • Xu, Zongli
  • Huang, Rae-Chi
  • Reese, Sarah E.
  • Xu, Cheng-Jian
  • Baiz, Nour
  • Hoyo, Cathrine
  • Agha, Golareh
  • Roy, Ritu
  • Holloway, John W.
  • Ghantous, Akram
  • Merid, Simon Kebede
  • Bakulski, Kelly M.
  • Kupers, Leanne K.
  • Zhang, Hongmei
  • Richmond, Rebecca C.
  • Page, Christian Magnus
  • Duijts, Liesbeth
  • Lie, Rolv T.
  • Melton, Phillip E.
  • Vonk, Judith M.
  • Nohr, Ellen Aagard
  • Williams-DeVane, ClarLynda
  • Huen, Karen
  • Rifas-Shiman, Sheryl L.
  • Ruiz Arenas, Carlos
  • Gonseth, Semira
  • Rezwan, Faisal I.
  • Herceg, Zdenko
  • Ekstrom, Sandra
  • Croen, Lisa
  • Falahi, Fahimeh
  • Perron, Patrice
  • Karagas, Margaret R.
  • Quraishi, Bilal M.
  • Suderman, Matthew
  • Magnus, Maria C.
  • Jaddoe, Vincent W.
  • Taylor, Jack A.
  • Anderson, Denise
  • Zhao, Shanshan
  • Smit, Henriette A.
  • Josey, Michele J.
  • Bradman, Asa
  • Baccarelli, Andrea A.
  • Bustamante Pineda, Mariona
  • Haberg, Siri E.
  • Pershagen, Göran
  • Hertz-Picciotto, Irva
  • Newschaffer, Craig
  • Corpeleijn, Eva
  • Bouchard, Luigi
  • Lawlor, Debbie A.
  • Maguire, Rachel L.
  • Barcellos, Lisa F.
  • Davey Smith, George
  • Eskenazi, Brenda
  • Karmaus, Wilfried
  • Marsit, Carmen J.
  • Hivert, Marie-France
  • Snieder, Harold
  • Fallin, M. Daniele
  • Melén, Erik
  • Munthe-Kaas, Monica C.
  • Arshad, Hasan
  • Wiemels, Joseph L.
  • Annesi-Maesano, Isabella
  • Vrijheid, Martine
  • Oken, Emily
  • Holland, Nina
  • Murphy, Susan K.
  • Sorensen, Thorkild I. A.
  • Koppelman, Gerard H.
  • Newnham, John P.
  • Wilcox, Allen J.
  • Nystad, Wenche
  • London, Stephanie J.
  • Felix, Janine F.
  • Relton, Caroline L.
Pre-pregnancy maternal obesity is associated with adverse offspring outcomes at birth and later in life. Individual studies have shown that epigenetic modifications such as DNA methylation could contribute. Within the Pregnancy and Childhood Epigenetics (PACE) Consortium, we meta-analysed the association between pre-pregnancy maternal BMI and methylation at over 450,000 sites in newborn blood DNA, across 19 cohorts (9,340 mother-newborn pairs). We attempted to infer causality by comparing the effects of maternal versus paternal BMI and incorporating genetic variation. In four additional cohorts (1,817 mother-child pairs), we meta-analysed the association between maternal BMI at the start of pregnancy and blood methylation in adolescents. In newborns, maternal BMI was associated with small (<0.2% per BMI unit (1 kg/m2), P < 1.06 x 10-7) methylation variation at 9,044 sites throughout the genome. Adjustment for estimated cell proportions greatly attenuated the number of significant CpGs to 104, including 86 sites common to the unadjusted model. At 72/86 sites, the direction of the association was the same in newborns and adolescents, suggesting persistence of signals. However, we found evidence for acausal intrauterine effect of maternal BMI on newborn methylation at just 8/86 sites. In conclusion, this well-powered analysis identified robust associations between maternal adiposity and variations in newborn blood DNA methylation, but these small effects may be better explained by genetic or lifestyle factors than a causal intrauterine mechanism. This highlights the need for large-scale collaborative approaches and the application of causal inference techniques in epigenetic epidemiology.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Maternal and fetal genetic contribution to gestational weight gain

  • Warrington, Nicole M.
  • Richmond, Rebecca C.
  • Fenstra, Bjarke
  • Myhre, Ronny
  • Gaillard, Romy
  • Paternoster, Lavinia
  • Wang, Carol A.
  • Beaumont, Robin N.
  • Das, Shikta
  • Murcia, Mario
  • Barton, Sheila J.
  • Espinosa Cardiel, Ana
  • Thiering, Elisabeth
  • Atalay, Mustafa
  • Pitkanen, Niina
  • Ntalla, Ioanna
  • Jonsson, Anna E.
  • Freathy, Rachel M.
  • Karhunen, Ville
  • Tiesler, Carla M. T.
  • Allard, Catherine
  • Crawford, Andrew
  • Ring, Susan M.
  • Melbye, Mads
  • Magnus, Per
  • Rivadeneira, Fernando
  • Skotte, Line
  • Hansen, Torben
  • Marsh, Julie A.
  • Guxens, Mònica
  • Holloway, John W.
  • Grallert, Harald
  • Jaddoe, Vincent W.
  • Lowe, William L.
  • Roumeliotaki, Theano
  • Hattersley, Andrew T.
  • Lindi, Virpi
  • Pahkala, Katja
  • Panoutsopoulou, Kalliope
  • Standl, Marie
  • Flexeder, Claudia
  • Bouchard, Luigi
  • Nohr, Ellen Aagard
  • Marina, Loreto Santa
  • Kogevinas, Manolis
  • Niinikoski, Harri
  • Dedoussis, George
  • Heinrich, Joachim
  • Reynolds, Rebecca M.
  • Lakka, Timo
  • Zeggini, Eleftheria
  • Raitakari, Olli T.
  • Chatzi, Leda
  • Inskip, Hazel M.
  • Bustamante Pineda, Mariona
  • Hivert, Marie-France
  • Jarvelin, Marjo-Riitta
  • Sorensen, Thorkild I. A.
  • Pennell, Craig E.
  • Felix, Janine F.
  • Jacobsson, Bo
  • Geller, Frank
  • Evans, David M.
  • Lawlor, Debbie A.
BACKGROUND: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG. PARTICIPANTS AND METHODS: A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (e.g. maternal BMI and glucose, birthweight). RESULTS: Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explaining variation in GWG. Variants near the Pregnancy Specific Beta-1-Glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 x 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birthweight variants were largely unrelated to GWG. CONCLUSION: We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.International Journal of Obesity accepted article preview online, 09 October 2017. doi:10.1038/ijo.2017.248.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics

  • Beaumont, Robin N.
  • Warrington, Nicole M.
  • Cavadino, Alana
  • Tyrrell, Jessica
  • Nodzenski, Michael
  • Horikoshi, Momoko
  • Geller, Frank
  • Myhre, Ronny
  • Richmond, Rebecca C.
  • Paternoster, Lavinia
  • Bradfield, Jonathan P.
  • Kreiner-Moller, Eskil
  • Huikari, Ville
  • Metrustry, Sarah
  • Lunetta, Kathryn L.
  • Painter, Jodie N.
  • Hottenga, Jouke-Jan
  • Allard, Catherine
  • Barton, Sheila J.
  • Espinosa Cardiel, Ana
  • Marsh, Julie A.
  • Potter, Catherine
  • Zhang, Ge
  • Ang, Wei
  • Berry, Diane J.
  • Bouchard, Luigi
  • Das, Shikta
  • Early Growth Genetics (EGG) Consortium
  • Hakonarson, Hakon
  • Heikkinen, Jani
  • Helgeland, Øyvind
  • Hocher, Berthold
  • Hofman, Albert
  • Inskip, Hazel M.
  • Jones, Samuel E.
  • Kogevinas, Manolis
  • Lind, Penelope A.
  • Marullo, Letizia
  • Medland, Sarah E.
  • Murray, Anna
  • Murray, Jeffrey C.
  • Njolstad, Pal R.
  • Nohr, Ellen Aagard
  • Reichetzeder, Christoph
  • Ring, Susan M.
  • Ruth, Katherine S.
  • Santa Marina, Loreto
  • Scholtens, Denise M.
  • Sebert, Sylvain
  • Sengpiel, Verena
  • Tuke, Marcus A.
  • Vaudel, Marc
  • Weedon, Michael N.
  • Willemsen, Gonneke
  • Wood, Andrew R.
  • Yaghootkar, Hanieh
  • Muglia, Louis J.
  • Bartels, Meike
  • Relton, Caroline L.
  • Pennell, Craig E.
  • Chatzi, Leda
  • Estivill, Xavier, 1955-
  • Holloway, John W.
  • Boomsma, Dorret I.
  • Montgomery, Grant W.
  • Murabito, Joanne M.
  • Spector, Tim D.
  • Power, Christine
  • Järvelin, Marjo-Ritta
  • Bisgaard, Hans
  • Grant, Struan F.
  • Sorensen, Thorkild I. A.
  • Jaddoe, Vincent W.
  • Jacobsson, Bo
  • Melbye, Mads
  • McCarthy, Mark I.
  • Hattersley, Andrew T.
  • Hayes, M. Geoffrey
  • Frayling, Timothy M.
  • Hivert, Marie-France
  • Felix, Janine F.
  • Hyppönen, Elina
  • Lowe, William L.
  • Evans, David M.
  • Lawlor, Debbie A.
  • Feenstra, Bjarke
  • Freathy, Rachel M.
Genome-wide association studies of birth weight have focused on fetal genetics, whereas relatively little is known about the role of maternal genetic variation. We aimed to identify maternal genetic variants associated with birth weight that could highlight potentially relevant maternal determinants of fetal growth. We meta-analysed data on up to 8.7 million SNPs in up to 86 577 women of European descent from the Early Growth Genetics (EGG) Consortium and the UK Biobank. We used structural equation modelling (SEM) and analyses of mother–child pairs to quantify the separate maternal and fetal genetic effects. Maternal SNPs at 10 loci (MTNR1B, HMGA2, SH2B3, KCNAB1, L3MBTL3, GCK, EBF1, TCF7L2, ACTL9, CYP3A7) were associated with offspring birth weight at P < 5 × 10−8. In SEM analyses, at least 7 of the 10 associations were consistent with effects of the maternal genotype acting via the intrauterine environment, rather than via effects of shared alleles with the fetus. Variants, or correlated proxies, at many of the loci had been previously associated with adult traits, including fasting glucose (MTNR1B, GCK and TCF7L2) and sex hormone levels (CYP3A7), and one (EBF1) with gestational duration. The identified associations indicate that genetic effects on maternal glucose, cytochrome P450 activity and gestational duration, and potentially on maternal blood pressure and immune function, are relevant for fetal growth. Further characterization of these associations in mechanistic and causal analyses will enhance understanding of the potentially modifiable maternal determinants of fetal growth, with the goal of reducing the morbidity and mortality associated with low and high birth weights.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Epigenome-Wide Meta-Analysis of Methylation in Children Related to Prenatal NO2 Air Pollution Exposure

  • Gruzieva, Olena
  • Xu, Cheng-Jian
  • Breton, Carrie V.
  • Annesi-Maesano, Isabella
  • Antó i Boqué, Josep Maria
  • Auffray, Charles
  • Ballereau, Stephane
  • Bellander, Tom
  • Bousquet, Jean
  • Bustamante Pineda, Mariona
  • Charles, Marie-Aline
  • Kluizenaar, Yvonne de
  • Dekker, Herman T. den
  • Duijts, Liesbeth
  • Felix, Janine F.
  • Gehring, Ulrike
  • Guxens, Mònica
  • Jaddoe, Vincent W.
  • Jankipersadsing, Soesma A.
  • Merid, Simon Kebede
  • Kere, Juha
  • Kumar, Ashish
  • Lemonnier, Nathanael
  • Lepeule, Johanna
  • Nystad, Wenche
  • Page, Christian Magnus
  • Panasevich, Sviatlana
  • Postma, Dirkje S.
  • Slama, Rémy
  • Sunyer Deu, Jordi
  • Soderhall, Cilla
  • Yao, Jin
  • London, Stephanie J.
  • Pershagen, Göran
  • Koppelman, Gerard H.
  • Melén, Erik
BACKGROUND: Prenatal exposure to air pollution is considered to be associated with adverse effects on child health. This may partly be mediated by mechanisms related to DNA methylation. OBJECTIVES: We investigated associations between exposure to air pollution, using nitrogen dioxide (NO2) as marker, and epigenome-wide cord blood DNA methylation. METHODS: We meta-analyzed the associations between NO2 exposure at residential addresses during pregnancy and cord blood DNA methylation (Illumina 450K) in four European and North-American studies (n=1,508) with subsequent look-up analyses in children aged 4 (n=733) and 8 (n=786) years. Additionally, we applied a literature-based candidate approach for antioxidant and anti-inflammatory genes. To assess influence of exposure at the transcriptomics level, we related mRNA expression in blood cells to NO2 exposure in 4- (n=111) and 16-year-olds (n=239). RESULTS: We found epigenome-wide significant associations (false discovery rate (FDR) p<0.05) between maternal NO2 exposure during pregnancy and DNA methylation in newborns for 3 CpG sites in mitochondria-related genes: cg12283362 (LONP1), cg24172570 (3.8 kbp upstream of HIBADH), and cg08973675 (SLC25A28). The associations with cg08973675 methylation were also significant in the older children. Further analysis of antioxidant and anti-inflammatory genes revealed differentially methylated CpGs in CAT and TPO in newborns (FDR p<0.05). NO2 exposure at the time of biosampling in childhood had significant impact on CAT and TPO expression. CONCLUSIONS: NO2 exposure during pregnancy was associated with differential offspring DNA methylation in mitochondria-related genes. Exposure to NO2 was also linked to differential methylation as well as expression of genes involved in antioxidant defense pathways.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium

  • Felix, Janine F.
  • Joubert, Bonnie R.
  • Baccarelli, Andrea A.
  • Sharp, Gemma C.
  • Almqvist, Catarina
  • Annesi-Maesano, Isabella
  • Arshad, Hasan
  • Baiz, Nour
  • Bakermans-Kranenburg, Marian J.
  • Bakulski, Kelly M.
  • Binder, Elisabeth B.
  • Plusquin, Michelle
  • Tiemeier, Henning
  • Räikkönen, Katri
  • Rzehak, Peter
  • Wang, Pei
  • Reese, Sarah E.
  • Reischl, Eva
  • Richiardi, Lorenzo
  • Ring, Susan M.
  • Schwartz, David A.
  • Wiemels, Joseph L.
  • Taylor, Jack A.
  • Yousefi, Paul
  • Sebert, Sylvain
  • Snieder, Harold
  • Sorensen, Thorkild I. A.
  • Starling, Anne P.
  • Ullemar, Vilhelmina
  • Zhang, Weiming
  • Vafeiadi, Marina
  • Bouchard, Luigi
  • Brunekreef, Bert
  • Van Ijzendoorn, Marinus H.
  • Vonk, Judith M.
  • Vriens, Annette
  • Vrijheid, Martine
  • Wilcox, Allen J.
  • Zhang, Hongmei
  • Czamara, Darina
  • Wright, Rosalind J.
  • Xu, Cheng-Jian
  • Xu, Zongli
  • Yang, Ivana V.
  • Zhao, Shanshan
  • Davey Smith, George
  • Breton, Carrie V.
  • Everson, Todd M.
  • Agha, Golareh
  • Relton, Caroline L.
  • Jaddoe, Vincent W.
  • London, Stephanie J.
  • Brunst, Kelly J.
  • Fallin, M. Daniele
  • Burchard, Esteban G.
  • Dabelea, Dana
  • Gonseth, Semira
  • Bustamante Pineda, Mariona
  • Chatzi, Leda
  • Cheng Munthe-Kaas, Monica
  • Corpeleijn, Eva
  • De Boever, Patrick
  • Falahi, Fahimeh
  • Holloway, John W.
  • Duijts, Liesbeth
  • Dwyer, Terence
  • Eng, Celeste
  • Eskenazi, Brenda
  • Farchi, Sara
  • Hu, Donglei
  • Fernandez, Mariana F.
  • Karagas, Margaret R.
  • Gao, Lu
  • Gaunt, Tom R.
  • Ghantous, Akram
  • Gillman, Matthew W.
  • Grote, Veit
  • Karmaus, Wilfried
  • Gruzieva, Olena
  • Hoyo, Cathrine
  • Ladd-Acosta, Christine
  • Haberg, Siri E.
  • Herceg, Zdenko
  • Hivert, Marie-France
  • Holland, Nina
  • Huang, Rae-Chi
  • Karlsson, Robert
  • Magnus, Per
  • Huen, Karen
  • Jarvelin, Marjo-Riitta
  • Jima, Dereje D.
  • Just, Allan C.
  • Kechris, Katerina J.
  • Marsit, Carmen J.
  • Kere, Juha
  • Nistico, Lorenza
  • Kogevinas, Manolis
  • Koletzko, B. (Berthold)
  • Koppelman, Gerard H.
  • Kupers, Leanne K.
  • Lahti, Jari
  • Nordlund, Bjorn
  • Lambrechts, Nathalie
  • Maguire, Rachel L.
  • Pizzi, Costanza
  • Langie, Sabine A. S.
  • Lie, Rolv T.
  • Liu, Andrew H.
  • Magnus, Maria C.
  • McArdle, Wendy
  • Nohr, Ellen Aagard
  • Roy, Ritu
  • Melén, Erik
  • Melton, Phillip E.
  • Murphy, Susan K.
  • Nawrot, Tim S.
  • Nystad, Wenche
  • Schoeters, Greet
  • Oh, Sam S.
  • Sunyer Deu, Jordi
  • Oken, Emily
  • Page, Christian Magnus
  • Perron, Patrice
  • Pershagen, Göran
Epigenetics refers to mitotically heritable changes to the DNA, which do not affect the DNA sequence, but can influence its function. Currently, DNA methylation is the most studied epigenetic phenomenon in large populations. It entails the binding of a methyl group, mainly to positions in genomic DNA where a cytosine is located next to a guanine, a cytosine-phosphate-guanine (CpG) site (Figure 1). DNA methylation at CpG sites can influence gene expression by altering the DNA’s three-dimensional structure and interacting with methyl-binding proteins, consequently affecting the binding of the gene transcription and chromatin-modifying machinery. There are approximately 28 million CpG sites in the human genome. DNA methylation is a dynamic process that can be influenced by genetic factors, as well as by environmental factors such as diet, air pollution, toxicants or smoking.1–4 Hence, DNA methylation may be seen as linking the genome to the environment with respect to health and disease. Early development is a period of profound changes in DNA methylation and may, as such, be a critical period for environmentally-induced DNA methylation changes.4 Hence, this period is of specific interest for DNA methylation studies in relation to specific exposures and long-term health outcomes
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Occupational Exposure to Endocrine-Disrupting Chemicals and Birth Weight and Length of Gestation: A European Meta-Analysis

  • Birks, Laura
  • Casas, Maribel
  • Garcia, Ana M.
  • Alexander, Jan
  • Barros, Henrique
  • Bergstrom, Anna
  • Bonde, Jens Peter
  • Burdorf, Alex
  • Costet, Nathalie
  • Danileviciute, Asta
  • Eggesbo, Merete
  • Fernández, Mariana F.
  • González Galarzo, M. Carmen
  • Grazuleviciene, Regina
  • Hanke, Wojciech
  • Jaddoe, Vincent W.
  • Kogevinas, Manolis
  • Kull, Inger
  • Lertxundi, Aitana
  • Melaki, Vasiliki
  • Nybo Andersen, Anne-Marie
  • Olea, Nicolás
  • Polanska, Kinga
  • Rusconi, Franca
  • Santa Marina, Loreto
  • Santos, Ana Cristina
  • Vrijkotte, Tanja
  • Zugna, Daniela
  • Nieuwenhuijsen, Mark J.
  • Cordier, Sylvaine
  • Vrijheid, Martine
BACKGROUND: Women of reproductive age can be exposed to endocrine-disrupting chemicals (EDCs) at work and exposure to EDCs in pregnancy may affect fetal growth. OBJECTIVES: We assessed whether maternal occupational exposure to EDCs during pregnancy as classified by application of a job exposure matrix was associated with birth weight, term low birth weight (LBW), length of gestation, and preterm delivery. METHODS: Using individual participant data from 133,957 mother-child pairs in 13 European cohorts spanning births from 1994 to 2011, we linked maternal job titles with exposure to 10 EDC groups as assessed through a job exposure matrix. For each group, we combined the two levels of exposure categories (possible and probable) and compared birth outcomes with the unexposed group (exposure unlikely). We performed meta-analyses of cohort-specific estimates. RESULTS: Eleven percent of pregnant women were classified as exposed to EDCs at work during pregnancy based on job title. Classification of exposure to one or more EDC group was associated with an increased risk of term LBW (OR 1.25, 95%CI 1.04, 1.49), as were most specific EDC groups; this association was consistent across cohorts. Further, the risk increased with increasing number of EDC groups (OR 2.11 95%CI 1.10, 4.06 for exposure to 4 or more EDC groups). There were few associations (p < 0.05) with the other outcomes; women holding job titles classified as exposed to bisphenol A or brominated flame retardants were at higher risk for longer length of gestation. CONCLUSION: Results from our large population-based birth cohort design indicate that employment during pregnancy in occupations classified as possibly or probably exposed to EDCs was associated with an increased risk of term LBW.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania

  • Santos, Susana
  • Vrijheid, Martine
  • Jaddoe, Vincent W. V.
Background: Gestational weight gain differs according to pre-pregnancy body mass index and is related to the risks of adverse maternal and child health outcomes. Gestational weight gain charts for women in different pre-pregnancy body mass index groups enable identification of women and offspring at risk for adverse health outcomes. We aimed to construct gestational weight gain reference charts for underweight, normal weight, overweight, and grades 1, 2 and 3 obese women and to compare these charts with those obtained in women with uncomplicated term pregnancies. Methods: We used individual participant data from 218,216 pregnant women participating in 33 cohorts from Europe, North America, and Oceania. Of these women, 9065 (4.2%), 148,697 (68.1%), 42,678 (19.6%), 13,084 (6.0%), 3597 (1.6%), and 1095 (0.5%) were underweight, normal weight, overweight, and grades 1, 2, and 3 obese women, respectively. A total of 138, 517 women from 26 cohorts had pregnancies with no hypertensive or diabetic disorders and with term deliveries of appropriate for gestational age at birth infants. Gestational weight gain charts for underweight, normal weight, overweight, and grade 1, 2, and 3 obese women were derived by the Box-Cox t method using the generalized additive model for location, scale, and shape. Results: We observed that gestational weight gain strongly differed per maternal pre-pregnancy body mass index group. The median (interquartile range) gestational weight gain at 40 weeks was 14.2 kg (11.4-17.4) for underweight women, 14.5 kg (11.5-17.7) for normal weight women, 13.9 kg (10.1-17.9) for overweight women, and 11.2 kg (7.0-15.7), 8.7 kg (4.3-13.4) and 6.3 kg (1.9-11.1) for grades 1, 2, and 3 obese women, respectively. The rate of weight gain was lower in the first half than in the second half of pregnancy. No differences in the patterns of weight gain were observed between cohorts or countries. Similar weight gain patterns were observed in mothers without pregnancy complications. Conclusions: Gestational weight gain patterns are strongly related to pre-pregnancy body mass index. The derived charts can be used to assess gestational weight gain in etiological research and as a monitoring tool for weight gain during pregnancy in clinical practice., ALSPAC: The UK Medical Research Council and Wellcome (Grant ref.: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This study has received support from the US National Institute of Health (R01 DK10324) and European Research Council under the European Union’s Seventh Framework Programme (FP7/2007–2013)/ERC grant agreement no 669545. DA Lawlor works in a unit that receives UK MRC funding (MC_UU_12013/5) and is an NIHR senior investigator (NF-SI-0611-10196). Generation R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. Research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition under grant agreement no. 289346, the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 633595 (DynaHEALTH) and the European Union’s Horizon 2020 research and innovation programme under grant agreement 733206 (LifeCycle Project). Romy Gaillard received funding from the Dutch Heart Foundation (grant number 2017T013) and the Dutch Diabetes Foundation (grant number 2017.81.002). Vincent Jaddoe received grants from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (Consolidator Grant, ERC-2014-CoG-648916). HUMIS: European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreements Early Nutrition no. 289346 and by funds from the Norwegian Research Council’s MILPAAHEL programme, project no. 213148. INMA-Valencia: This study was funded by Grants from UE (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), and Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249).RHEA: The “Rhea” project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No. 211250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No. 226285 ENRIECO, EU-FP7-HEALTH-2012 Proposal No. 308333 HELIX) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion District, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–15). SWS: The SWS is supported by grants from the Medical Research Council, National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, and the European Union’s Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition (grant 289346). Study participants were drawn from a cohort study funded by the Medical Research Council and the Dunhill Medical Trust.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomes

  • Borges, Maria Carolina
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Lawlor, Deborah
Background: Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear. Methods: We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women. Results: All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation. Conclusions: Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications. Funding: Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust., This study was supported by the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00032/05), British Heart Foundation (AA/18/1/34219), the European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545), the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206 (LifeCycle), the US National Institutes of Health (R01 DK10324, U01 HG004415), the Bristol NIHR Biomedical Research Centre, and the Research Council of Norway through its Centres of Excellence funding scheme (project number 262700), and the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author-Accepted Manuscript version arising from this submission. MCB has received support from MRC Skills Development Fellowship (MR/P014054/1) and the University of Bristol Vice-Chancellor’s Fellowship. DAL is a British Heart Foundation Chair (CH/F/20/90003) and NIHR Senior Investigator (NF-0616–10102). JT is supported by an Academy of Medical Sciences (AMS) Springboard Award, which is supported by the AMS, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK [SBF004\1079]. RMF was funded by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (WT104150) and is now funded by a Wellcome Trust Senior Research Fellowship (WT220390). RG received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002), and the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109). VWVJ received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). XL received support from the Nordic Center of Excellence in Health-Related e-Sciences. LS reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899). BF was supported by an Oak Foundation Fellowship and by a grant from the Novo Nordisk Foundation (12,955). MCM has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). TAB is supported by the Medical Research Council (MRC) (UK) (MR/K501281/1), the NHMRC (Australia) (GNT1183074 and GNT1157714), and the British Heart Foundation Accelerator Award at the University of Bristol (AA/18/1/34219) and works in/is affiliated with a unit that is supported by the UK Medical Research Council (MC_UU_00011/6). LB is a senior research scholar from the Fonds de la recherche du Québec-Santé (FRQ-S) and a member of the FRQ-S-funded Centre de recherche du CHUS. MFH was supported by an American Diabetes Association (ADA) Pathways Accelerator Award (1–15-ACE-26). SEH and MCM are partly funded by the Research Council of Norway (project no. 320656) and through its Centres of Excellence funding scheme (project No 262700). JW and RMc are supported by the National Institute for Health and Care Research under its Applied Research Collaboration, Yorkshire and Humber (NIHR200166).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI

  • Couto Alves, Alexessander
  • Estivill, Xavier, 1955-
  • Sunyer Deu, Jordi
  • Early Growth Genetics (EGG) Consortium
Early childhood growth patterns are associated with adult health, yet the genetic factors and the developmental stages involved are not fully understood. Here, we combine genome-wide association studies with modeling of longitudinal growth traits to study the genetics of infant and child growth, followed by functional, pathway, genetic correlation, risk score, and colocalization analyses to determine how developmental timings, molecular pathways, and genetic determinants of these traits overlap with those of adult health. We found a robust overlap between the genetics of child and adult body mass index (BMI), with variants associated with adult BMI acting as early as 4 to 6 years old. However, we demonstrated a completely distinct genetic makeup for peak BMI during infancy, influenced by variation at the LEPR/LEPROT locus. These findings suggest that different genetic factors control infant and child BMI. In light of the obesity epidemic, these findings are important to inform the timing and targets of prevention strategies., All the authors acknowledge the following sponsors for support: UK Medical Research Council and Wellcome Trust (grant reference 102215/2/13/2); NIH grant R01 HD056465; Danish National Research Foundation; NIH Genes, Environment and Health Initiative (GEI; U01HG004423); NIH GEI (U01HG004438); Lundbeck Foundation (R19-A2059); Danish Medical Research Council (09-065592); French Ministry of Research; INSERM; South West NHS Research and Development; Exeter NHS Research and Development; Netherlands Organization for Health Research and Development (VIDI 016. 136. 361); European Union’s Horizon 2020 research and innovation programme under grant agreement nos. 633595 (DynaHEALTH), 733206 (LIFECYCLE), and 721567 (CAPICE); European Research Council (ERC consolidator grant, ERC-2014-CoG-648916); Academy of Finland (project grants 209072 and 129255); British Heart Foundation and Academy of Finland (grants 134839 and 129287); National Public Health Institute, Helsinki, Finland; World Cancer Research Fund (WCRF UK) and World Cancer Research Fund International (2017/1641); Wellcome Trust (WT205915); European Commission under the Marie Curie Intra-European Fellowship (project MARVEL, PIEF-GA-2013-626461); Instituto de Salud Carlos III (CB06/02/0041, FIS PI041436, PI081151, PI041705, and PS09/00432 and FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, and 09/02647); Spanish Ministry of Science and Innovation (SAF2008-00357); European Commission (ENGAGE project and grant agreement HEALTH-F4-2007-201413); Fundació La Marató de TV3; Generalitat de Catalunya-CIRIT 1999SGR 00241; Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296); National Health and Medical Research Council of Australia (grant IDs 403981 and 003209); Canadian Institutes of Health Research (grant ID MOP-82893); Royal Society of New Zealand Marsden Fund (grant 16-UOO-072); Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics, and SALVE); University Hospital Oulu; Biocenter; University of Oulu, Finland (75617); European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); NIH/NIMH (5R01MH63706:02); Medical Research Council, United Kingdom (G0500539 and G0600705, PrevMetSyn/SALVE, MR/M013138, G0802782); Wellcome Trust (project grant GR069224); and EU Framework Programme 7 EurHEALTHAgeing 277849. This research was conducted using the UK Biobank Resource.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium

  • Felix, Janine F.
  • Joubert, Bonnie R.
  • Baccarelli, Andrea A.
  • Sharp, Gemma C.
  • Almqvist, Catarina
  • Annesi-Maesano, Isabella
  • Arshad, Hasan
  • Baiz, Nour
  • Bakermans-Kranenburg, Marian J.
  • Bakulski, Kelly M.
  • Binder, Elisabeth B.
  • Plusquin, Michelle
  • Tiemeier, Henning
  • Raikkonen, Katri
  • Rzehak, Peter
  • Wang, Pei
  • Reese, Sarah E.
  • Reischl, Eva
  • Richiardi, Lorenzo
  • Ring, Susan M.
  • Schwartz, David A.
  • Wiemels, Joseph L.
  • Taylor, Jack A.
  • Yousefi, Paul
  • Sebert, Sylvain
  • Snieder, Harold
  • Sorensen, Thorkild I. A.
  • Starling, Anne P.
  • Ullemar, Vilhelmina
  • Zhang, Weiming
  • Vafeiadi, Marina
  • Bouchard, Luigi
  • Brunekreef, Bert
  • Van Ijzendoorn, Marinus H.
  • Vonk, Judith M.
  • Vriens, Annette
  • Vrijheid, Martine
  • Wilcox, Allen J.
  • Zhang, Hongmei
  • Czamara, Darina
  • Wright, Rosalind J.
  • Xu, Cheng-Jian
  • Xu, Zongli
  • Yang, Ivana V.
  • Zhao, Shanshan
  • Davey Smith, George
  • Breton, Carrie V.
  • Everson, Todd M.
  • Agha, Golareh
  • Relton, Caroline L.
  • Jaddoe, Vincent W.
  • London, Stephanie J.
  • Brunst, Kelly J.
  • Fallin, M. Daniele
  • Burchard, Esteban G.
  • Dabelea, Dana
  • Gonseth, Semira
  • Bustamante Pineda, Mariona
  • Chatzi, Leda
  • Cheng Munthe-Kaas, Monica
  • Corpeleijn, Eva
  • De Boever, Patrick
  • Falahi, Fahimeh
  • Holloway, John W.
  • Duijts, Liesbeth
  • Dwyer, Terence
  • Eng, Celeste
  • Eskenazi, Brenda
  • Farchi, Sara
  • Hu, Donglei
  • Fernandez, Mariana F.
  • Karagas, Margaret R.
  • Gao, Lu
  • Gaunt, Tom R.
  • Ghantous, Akram
  • Gillman, Matthew W.
  • Grote, Veit
  • Karmaus, Wilfried
  • Gruzieva, Olena
  • Hoyo, Cathrine
  • Ladd-Acosta, Christine
  • Haberg, Siri E.
  • Herceg, Zdenko
  • Hivert, Marie-France
  • Holland, Nina
  • Huang, Rae-Chi
  • Karlsson, Robert
  • Magnus, Per
  • Huen, Karen
  • Jarvelin, Marjo-Riitta
  • Jima, Dereje D.
  • Just, Allan C.
  • Kechris, Katerina J.
  • Marsit, Carmen J.
  • Kere, Juha
  • Nistico, Lorenza
  • Kogevinas, Manolis
  • Koletzko, B. (Berthold)
  • Koppelman, Gerard H.
  • Kupers, Leanne K.
  • Lahti, Jari
  • Nordlund, Bjorn
  • Lambrechts, Nathalie
  • Maguire, Rachel L.
  • Pizzi, Costanza
  • Langie, Sabine A. S.
  • Lie, Rolv T.
  • Liu, Andrew H.
  • Magnus, Maria C.
  • McArdle, Wendy
  • Nohr, Ellen Aagard
  • Roy, Ritu
  • Melén, Erik
  • Melton, Phillip E.
  • Murphy, Susan K.
  • Nawrot, Tim S.
  • Nystad, Wenche
  • Schoeters, Greet
  • Oh, Sam S.
  • Sunyer Deu, Jordi
  • Oken, Emily
  • Page, Christian Magnus
  • Perron, Patrice
  • Pershagen, Göran
Epigenetics refers to mitotically heritable changes to the DNA, which do not affect the DNA sequence, but can influence its function. Currently, DNA methylation is the most studied epigenetic phenomenon in large populations. It entails the binding of a methyl group, mainly to positions in genomic DNA where a cytosine is located next to a guanine, a cytosine-phosphate-guanine (CpG) site (Figure 1). DNA methylation at CpG sites can influence gene expression by altering the DNA’s three-dimensional structure and interacting with methyl-binding proteins, consequently affecting the binding of the gene transcription and chromatin-modifying machinery. There are approximately 28 million CpG sites in the human genome. DNA methylation is a dynamic process that can be influenced by genetic factors, as well as by environmental factors such as diet, air pollution, toxicants or smoking.1–4 Hence, DNA methylation may be seen as linking the genome to the environment with respect to health and disease. Early development is a period of profound changes in DNA methylation and may, as such, be a critical period for environmentally-induced DNA methylation changes.4 Hence, this period is of specific interest for DNA methylation studies in relation to specific exposures and long-term health outcomes
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Associations of green and blue space exposure in pregnancy with epigenetic gestational age acceleration

  • Marques, Irene
  • Santos, Susana
  • Monasso, Giulietta S.
  • Fossati, Serena
  • Vrijheid, Martine
  • Nieuwenhuijsen, Mark
  • Jaddoe, Vincent W. V.
  • Felix, Janine Frédérique
Early life is seen as a particularly sensitive period for environmental exposures. Natural space exposure during pregnancy has been associated with offspring health. Epigenetic gestational age acceleration, a discrepancy between clinical and DNA methylation-based gestational age, may underlie these associations. In 1359 mother-newborn pairs from the population-based Generation R Study, we examined the associations of natural space exposure, defined as surrounding greenness, distance to major green and blue (water) space, and size of the blue space during pregnancy with offspring epigenetic gestational age acceleration. Natural space exposure was based on participants’ geocoded addresses, and epigenetic gestational age acceleration was calculated from cord blood DNA methylation using Bohlin’s and Knight’s epigenetic clocks. Sensitivity analyses were conducted in a subgroup of newborns with optimal pregnancy dating, based on last menstrual period. Surrounding greenness, measured in normalized difference vegetation index values, was intermediate (median 0.4, IQR 0.2), and 84% and 56% of the participants had a major green or blue space near their home address, respectively. We did not observe associations of natural space availability during pregnancy with offspring epigenetic gestational age acceleration. This could imply that epigenetic gestational age acceleration in cord blood does not underlie the effects of residential natural space availability in pregnancy on offspring health. Future studies could investigate whether residential natural space availability during pregnancy is associated with offspring differential DNA methylation at other CpGs than those included in the epigenetic gestational clocks., The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Netherlands Organization for Scientific Research (NWO), the Ministry of Health, Welfare and Sport, and the Ministry of Youth and Families. The EWAS data was funded by a grant to VWVJ from the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA; project number 050-060-810), by funds from the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam (R01HD068437). VWVJ received funding from the European Research Council (ERC-2014-CoG-648916). The project was supported by funding from the European Union’s Horizon 2020 research and innovation program under grant agreements No 733206 (LifeCycle), 874739 (LongITools) and 874583 (ATHLETE), and from the European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL, NutriPROGRAM project, ZonMw the Netherlands no. 529051022 and PREcisE project ZonMw the Netherlands no. 529051023).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prenatal exposure to nonpersistent chemical mixtures and fetal growth: a population-based study

  • Dries, Michiel A. van den
  • Keil, Alexander P.
  • Tiemeier, Henning
  • Pronk, Anjoeka
  • Spaan, Suzanne
  • Santos, Susana
  • Asimakopoulos, Alexandros G.
  • Kannan, Kurunthachalam
  • Gaillard, Romy
  • Guxens Junyent, Mònica
  • Trasande, Leonardo
  • Jaddoe, Vincent W. V.
  • Ferguson, Kelly K.
Background: Prenatal exposure to mixtures of nonpersistent chemicals is universal. Most studies examining these chemicals in association with fetal growth have been restricted to single exposure models, ignoring their potentially cumulative impact. Objective: We aimed to assess the association between prenatal exposure to a mixture of phthalates, bisphenols, and organophosphate (OP) pesticides and fetal measures of head circumference, femur length, and weight. Methods: Within the Generation R Study, a population-based cohort in Netherlands (n=776), urinary concentrations of 11 phthalate metabolites, 3 bisphenols, and 5 dialkylphosphate (DAP) metabolites were measured at <18, 18-25, and > 25 weeks of gestation and averaged. Ultrasound measures of head circumference, femur length, and estimated fetal weight (EFW) were taken at 18-25 and > 25 weeks of gestation, and measurements of head circumference, length, and weight were performed at delivery. We estimated the difference in each fetal measurement per quartile increase in all exposures within the mixture with quantile g-computation. Results: The average EFW at 18-25 wk and > 25 wk was 369 and 1,626g, respectively, and the average birth weight was 3,451g. Higher exposure was associated with smaller fetal and newborn growth parameters in a nonlinear fashion. At 18-25 wk, fetuses in the second, third, and fourth quartiles of exposure (Q2-Q4) had 26g [95% confidence intervals (CI): − 38, −13], 35g (95% CI:−55, −15), and 27g (95% CI: −54, 1) lower EFW compared with those in the first quartile (Q1). A similar dose-response pattern was observed at > 25wk, but all effect sizes were smaller, and no association was observed comparing Q4 to Q1. At birth, we observed no differences in weight between Q1-Q2 or Q1-Q3. However, fetuses in Q4 had 91g (95% CI: −258, 76) lower birth weight in comparison with those in Q1. Results observed at 18-25 and > 25wk were similar for femur length; however, no differences were observed at birth. No associations were observed for head circumference. Discussion: Higher exposure to a mixture of phthalates, bisphenols, and OP pesticides was associated with lower EFW in the midpregnancy period. In late pregnancy, these differences were similar but less pronounced. At birth, the only associations observed appeared when comparing individuals from Q1 and Q4. This finding suggests that even low levels of exposure may be sufficient to influence growth in early pregnancy, whereas higher levels may be necessary to affect birth weight. Joint exposure to nonpersistent chemicals may adversely impact fetal growth, and because these exposures are widespread, this impact could be substantial. https://doi.org/10.1289/EHP9178., This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) (ZIAES101575). It was additionally supported by grants from the NIH (RO1ES022972 and RO1ES029779) and NIEHS, NIH (HHSN273201500003C). H.T. was supported by the Netherlands Organization for Scientific Research (NWO) VICI grant (NWO-ZonMW: 016. VICI.170.200). M.G. is funded by a Miguel Servet fellowship (MS13/00054, CP18/00018) awarded by the Spanish Institute of Health Carlos III. We acknowledge support from the Spanish Ministry of Science and Innovation and the State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. The research leading to these results received funding from the European Union Horizon 2020 Research and Innovation Programme under Grant Agreement 733206 (LifeCycle), 874583 (ATHLETE) and 824989 (EUCAN-Connect). V.W.V.J. received grant ERC-2014-CoG-648916 from the European Research Council. R.G. received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002) and Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association of environmental noise exposure with cortisol levels in children from eight European birth cohorts

  • Arregi, Ane
  • Guxens Junyent, Mònica
  • Nieuwenhuijsen, Mark J.
  • Vrijheid, Martine
  • Lertxundi, Nerea
Environmental noise is a major environmental risk factor for public health. According to the noise reaction model the release of stress hormones like cortisol in response to noise exposure, plays a key role in the development of noise-induced health effects. We aimed to study the association between environmental noise with both acute (UCC) and cumulative (HCC) cortisol levels in children 5-12 years of age. To do so, we analysed data from the HELIX cohort -with spot UCC data- and from the Generation R and INMA cohorts (Gipuzkoa and Sabadell) -with HCC data. The analytical sample involved: 750 HELIX children (mean age = 7.75), 1326 Generation R children (mean age = 6.06), 111 INMA-Sabadell children (mean age = 8.75) and 288 INMA-Gipuzkoa children (mean age = 7.85). Day-evening-night equivalent (Lden) environmental noise exposure during the year of the follow-up was estimated in the addresses of participants, using existing noise maps. Directed acyclic graphs (DAGs) were used to identify appropriate covariates and reduce the chance for biased estimation. We used mixed-effects modelling and linear modelling to examine the association between Lden and cortisol concentration using complete case analyses. None of the models reached the statistical significance. We observed no correlation between HCC and UCC in INMA-Sabadell participants, for whom both urinary and hair cortisol data were available. Future research should prioritize investigating the effects of environmental noise on HCC, as it may serve as a more reliable indicator for assessing associations with chronic exposures. Additionally, future studies on noise-induced health effects in children should incorporate other biomarkers of stress and chronic inflammation to provide a more comprehensive understanding of these associations., The study was supported by the European Community's Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583; LongITools, grant agreement No 874739). Cortisol and related Glucocorticosteroids were measured within the HELIX cohorts as part of the UK Research and Innovation METAGE project (Grant ref: MR/S03532X/1). We further acknowledge funding from Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS464,445PI13/02187, FIS-PI18/01142 include FEDER funds, Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds, CPII18/00018), CIBERESP, Department of Health of the BasqueGovernment (2005111093, 2009111069, 2013111089 and 2015111065), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001, DFG15/221 and DFG89/17), Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), EU Commission (261357, 308333, 603794 and 634453). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. VJ received funding from a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report. BiB receives funding from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024391/1); the British Heart Foundation (CS/16/4/32482); a Wellcome Infrastructure Grant (WT101597MA); the National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber (NIHR200166). The National Institute for Health Research Clinical Research Network provided research delivery support for this study. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DRG), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007–2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). The “Rhea” project was financially supported by European projects (EU FP6–2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211250 Escape, EU FP7–2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU-FP7-HEALTH-2012 Proposal No 308333 HELIX, ATHLETE) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–2015). The funding bodies have not affected in any way the study and the presented results. KANC was funded by the grant of the Lithuanian Agency for Science Innovation and Technology (6-04-2014_31V-66). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children

  • van Meel, Evelien R.
  • Casas Sanahuja, Maribel
  • Kogevinas, Manolis
  • Sunyer Deu, Jordi
  • Duijts, Liesbeth
Background: Early-life respiratory tract infections might affect chronic obstructive respiratory diseases, but conclusive studies from general populations are lacking. Our objective was to examine if children with early-life respiratory tract infections had increased risks of lower lung function and asthma at school age. Methods: We used individual participant data of 150 090 children primarily from the EU Child Cohort Network to examine the associations of upper and lower respiratory tract infections from age 6 months to 5 years with forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC, forced expiratory flow at 75% of FVC (FEF75%) and asthma at a median (range) age of 7 (4-15) years. Results: Children with early-life lower, not upper, respiratory tract infections had a lower school-age FEV1, FEV1/FVC and FEF75% (z-score range: -0.09 (95% CI -0.14- -0.04) to -0.30 (95% CI -0.36- -0.24)). Children with early-life lower respiratory tract infections had a higher increased risk of school-age asthma than those with upper respiratory tract infections (OR range: 2.10 (95% CI 1.98-2.22) to 6.30 (95% CI 5.64-7.04) and 1.25 (95% CI 1.18-1.32) to 1.55 (95% CI 1.47-1.65), respectively). Adjustment for preceding respiratory tract infections slightly decreased the strength of the effects. Observed associations were similar for those with and without early-life wheezing as a proxy for early-life asthma. Conclusions: Our findings suggest that early-life respiratory tract infections affect development of chronic obstructive respiratory diseases in later life, with the strongest effects for lower respiratory tract infections., A comprehensive list of grant funding is available on the ALSPAC website (www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). BAMSE: BAMSE was funded by the Swedish Research Council, the Swedish Heart Lung Foundation, ALF Region Stockholm and SFO Epidemiology Karolinska Institutet. E. Mélen is supported by a European Research Council grant (TRIBAL, 757919). BiB (Born in Bradford): BiB is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all the participants, practitioners and researchers who have made BiB happen. The BiB study presents independent research commissioned by the National Institute for Health Research Collaboration for Applied Health Research and Care (NIHR CLAHRC) and the Programme Grants for Applied Research funding scheme (RP-PG-0407-10044). Core support for BiB is also provided by the Wellcome Trust (WT101597MA). BILD: This study was funded by the Swiss National Science Foundation (320030_163311). CoNER: Funds were obtained from the special programme (Programmi speciali – Art.12 bis, comma 6 D.lgs.229/99 Sanitaria e della Vigilanza sugli Enti) funded by the Italian Ministry of Health. Approval for the study was obtained from the Ethics Committee of the S. Orsola-Malpighi Teaching Hospital in April 2004 (52/2004/U/Tess). COPSAC 2000 and COPSAC 2010: All funding received by COPSAC is listed on www.copsac.com. The Lundbeck Foundation (R16-A1694), Ministry of Health (903516), Danish Council for Strategic Research (0603-00280B) and Capital Region Research Foundation have provided core support to the COPSAC research centre. We express our deepest gratitude to the children and families of the COPSAC 2000 and COPSAC 2010 cohort studies for all their support and commitment. We acknowledge and appreciate the unique efforts of the COPSAC research team. DNBC (Danish National Birth Cohort): The authors would like to thank the participants, the first Principal Investigator of DNBC, Jørn Olsen, the scientific managerial team and DNBC secretariat for being, establishing, developing and consolidating the DNBC. The DNBC was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, Pharmacy Foundation, Egmont Foundation, March of Dimes Birth Defects Foundation, Health Foundation and other minor grants. The DNBC Biobank has been supported by the Novo Nordisk Foundation and Lundbeck Foundation. Follow-up of mothers and children has been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B), Lundbeck Foundation (195/04, R100-A9193), Innovation Fund Denmark 0603-00294B (09-067124), Nordea Foundation (02-2013-2014), Aarhus Ideas (AU R9-A959-13-S804), University of Copenhagen Strategic Grant (IFSV 2012) and Danish Council for Independent Research (DFF-4183-00594, DFF-4183-00152). A. Pinot de Moira is funded by a Lundbeck Foundation grant (R264-2017-3099). EDEN: We thank the EDEN mother–child cohort study group (I. Annesi-Maesano, J.Y. Bernard, J. Botton, M.A. Charles, P. Dargent-Molina, B. de Lauzon-Guillain, P. Ducimetière, M. de Agostini, B. Foliguet, A. Forhan, X. Fritel, A. Germa, V. Goua, R. Hankard, B. Heude, M. Kaminski, B. Larroque†, N. Lelong, J. Lepeule, G. Magnin, L. Marchand, C. Nabet, F. Pierre, R. Slama, M.J. Saurel-Cubizolles, M. Schweitzer and O. Thiebaugeorges). We thank all funding sources for the EDEN study (not allocated for the present study but for the cohort): Foundation for Medical Research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 programme), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, MeDALL projects), Diabetes National Research Program (in collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l'Education Nationale complementary health insurance (MGEN), French national agency for food security, and French speaking association for the study of diabetes and metabolism (ALFEDIAM). The funding source had no involvement in the conception of the present study. FLEHS: This study was conducted within the framework of the Flemish Centre of Expertise on Environment and Health, funded by the Dept of the Environment of the Flemish Government, Flemish Agency of Care and Health, and Flemish Dept of Economy, Science and Innovation. GASPII: The GASPII cohort was funded by the Italian Ministry of Health (2001), the research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement 261357 (MeDALL). Generation R: This study was funded by Erasmus MC Rotterdam, Erasmus University Rotterdam and the Netherlands Organisation for Health Research and Development. V.W.V. Jaddoe received a grant from the European Research Council (ERC-2014-CoG-648916). L. Duijts received funding from cofunded ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL), Horizon 2020 (696295; 2017), the Netherlands Organisation for Health Research and Development (ZonMw; 529051014; 2017), Science Foundation Ireland (SFI/16/ERA-HDHL/3360), and European Union (ALPHABET project). The project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206, 2016; EUCAN-Connect 824989; ATHLETE, 874583). The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data or writing of this report. Generation XXI: Generation XXI was supported by the European Regional Development Fund (ERDF) through the Operational Programme Competitiveness and Internationalization and national funding from the Foundation for Science and Technology (FCT), Portuguese Ministry of Science, Technology and Higher Education, and by the Unidade de Investigação em Epidemiologia – Instituto de Saúde Pública da Universidade do Porto (EPIUnit) (UIDB/04750/2020), Administração Regional de Saúde Norte (Regional Dept of Ministry of Health) and Fundação Calouste Gulbenkian. A.C. Santos is founded by FCT Investigator contracts IF/01060/2015. GINI: The GINIplus study was mainly supported for the first 3 years by the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum München (former GSF) (observational arm). The 4- and 6-year follow-up examinations of the GINIplus study were covered from the respective budgets of the five study centres (Helmholtz Zentrum München (former GSF), Research Institute at Marien-Hospital, Wesel, LMU Munich, TU Munich and from 6 years onwards also from IUF – Leibniz Research Institute for Environmental Medicine at the University of Düsseldorf). HUMIS: We thank all mothers for participating in the HUMIS study. HUMIS was funded by a grant from the Norwegian Research Council (226402). The HUMIS study was approved by the Norwegian Data Inspectorate (2002/1398) and by the Regional Ethics Committee for Medical Research in Norway (S-02122), and the specific use in the current study was approved by the Ethics Committee as well (2010/1259/REK sør-øst). INMA: Gipuzkoa: This study was funded by grants from Instituto de Salud Carlos III (FIS-PI09/00090, FIS-PI18/01142 including FEDER funds), CIBERESP, Dept of Health of the Basque Government (2013111089) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia and Beasain). Menorca: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; 97/0588; 00/0021-2, PI061756; PS0901958, PI14/00677 including FEDER funds), CIBERESP, Beca de la IV convocatoria de Ayudas a la Investigación en Enfemerdades Neurodegeneratives de La Caixa, and EC contract QLK4-CT-200-00263. Sabadell: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 including FEDER funds), Generalitat de Catalunya-CIRIT 1999SGR 00241 and Fundació La marató de TV3 (090430). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M. Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and cofunded by the European Social Fund “Investing in your future”. Valencia: This study was funded by grants from the European Union (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), Spain: Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041; FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/00663; Miguel Servet-FEDER CP11/00178, CP15/00025, CPII16/00051), Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, UGP-15-249), and Alicia Koplowitz Foundation 2017. Isle of Wight: This study was funded by grants from the National Institutes of Health USA (R01HL082925), Asthma UK (364), Isle of Wight NHS Trust and the British Medical Association. KOALA: The collection of data relevant for this study was funded by grants from the Netherlands Organisation for Health Research and Development (ZonMw; 2100.0090) and the Netherlands Asthma Foundation (3.2.03.48, 3.2.07.022). The researchers are independent from the funders. The funders had no role in the study design, data analysis, interpretation of data or writing of this report. We thank the children and parents for their participation in the KOALA study. LRC (Leicestershire Respiratory Cohorts): This study was funded by grants from the Swiss National Science Foundation (SNF: 320030-182628, 320030-162820, 3233-069348, 3200-069349) and Asthma UK 07/048. Lifeways Cross-Generation Cohort Study: This study was funded by the Health Research Board, Ireland, and the Irish Dept of Health and Children's Health Promotion Policy Unit. LISA: The LISA study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum München (former GSF), Helmholtz Centre for Environmental Research – UFZ, Leipzig, Research Institute at Marien-Hospital Bad Honnef for the first 2 years. The 4-, 6-, 10- and 15-year follow-up examinations of the LISA study were covered from the respective budgets of the involved partners (Helmholtz Zentrum München (former GSF), Helmholtz Centre for Environmental Research – UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF – Leibniz Research Institute for Environmental Medicine at the University of Düsseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296). Further, the 15-year follow-up examination of the LISA study was supported by the Commission of the European Communities, the Seventh Framework Program: MeDALL project. This project has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (949906). LucKi: LucKi is supported by Child and Youth Health Care Zuyderland, Public Health Service South Limburg and Maastricht University. We thank all parents and children for their participation in LucKi. LUKAS: This study was funded by research grants from the Academy of Finland (139021, 287675, 296814, 296817, 308254); Juho Vainio Foundation; EVO/VTR funding; Päivikki and Sakari Sohlberg Foundation; Farmers’ Social Insurance Institution (Mela); Finnish Cultural Foundation; Foundation for Pediatric Research; European Union QLK4-CT-2001-00250; and Finnish Institute for Health and Welfare, Finland. MAS-90: This study was funded by grants from the German Federal Ministry of Education and Research (MBMF; 07015633m 07ALE27, 01EE9405/5, 01EE9406) and the German Research Foundation (DFG; KE1462/2-1). Millennium Cohort Study: This study was funded by the Economic and Social Research Council and a consortium of UK government funders. We are grateful to the participating families and the Centre for Longitudinal Studies (CLS), UCL Institute of Education, for the use of these data and to the UK Data Service for making them available. However, neither CLS nor the UK Data Service bear any responsibility for the analysis or interpretation of these data. This work was supported by the Welcome Trust (187389/B/08/Z). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this ongoing cohort study. This research was supported by the Research Council of Norway through its Centres of Excellence funding scheme (262700). NINFEA: The authors are grateful to all the participants of the NINFEA cohort. The NINFEA study was partially funded by the Compagnia San Paolo Foundation. This research was partially funded by the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206). PELAGIE: We are grateful to the families who participated and continue to participate in the study. The cohort is supported by INSERM and received funding from the French National Research Agency, Fondation de France, French Agency for Food, Environmental and Occupational Health & Safety, National Institute for Public Health Surveillance (InVS), French Ministry of Labour, and French Ministry of Ecology. PIAMA: This study was funded by the Netherlands Organisation of Health Research and Development, Netherlands Organisation for Scientific Research, Netherlands Asthma Fund, Netherlands Ministry of Spatial Planning, Housing and the Environment, and Netherlands Ministry of Health, Welfare and Sport. REPRO_PL: This study was funded by the National Science Center Poland (DEC-2014/15/B/N27/00998). Rhea: This study was funded by the European Union Social Fund and the Hellenic Ministry of Health (“Program of prevention and early diagnosis of obesity and neurodevelopment disorders in preschool age children in the prefecture of Heraklion, Crete, Greece”; MIS 349580, NSRF 2007–2013). Additional funding from the National Institute of Environmental Health Sciences (NIEHS) supported L. Chatzi (R01ES030691, R01ES029944, R01ES030364, R21ES029681, R21ES028903, P30ES007048). STEPS: This study was funded by the University of Turku, Abo Akademi University, Turku University Hospital, Academy of Finland (123571, 140251, 277535) and Foundation for Pediatric Research Finland. SWS: This study was funded by the Medical Research Council, British Heart Foundation, Arthritis Research UK, Food Standards Agency, NIHR Southampton Biomedical Research Centre and the European Union's Seventh Framework Programme (FP7/2007–2013), project EarlyNutrition (289346), and the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, 733206). WHISTLER: The WHISTLER birth cohort was supported with a grant from the Netherlands Organisation for Health Research and Development (2001-1-1322) and by an unrestricted grant from GlaxoSmithKline Netherlands. GlaxoSmithKline had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the report for publication. WHISTLER-Cardio was supported with an unrestricted strategic grant from the University Medical Center Utrecht (UMCU).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Occupational Exposure to Endocrine-Disrupting Chemicals and Birth Weight and Length of Gestation: A European Meta-Analysis

  • Birks, Laura
  • Casas, Maribel
  • Garcia, Ana M.
  • Alexander, Jan
  • Barros, Henrique
  • Bergstrom, Anna
  • Bonde, Jens Peter
  • Burdorf, Alex
  • Costet, Nathalie
  • Danileviciute, Asta
  • Eggesbo, Merete
  • Fernández, Mariana F.
  • González Galarzo, M. Carmen
  • Grazuleviciene, Regina
  • Hanke, Wojciech
  • Jaddoe, Vincent W.
  • Kogevinas, Manolis
  • Kull, Inger
  • Lertxundi, Aitana
  • Melaki, Vasiliki
  • Nybo Andersen, Anne-Marie
  • Olea, Nicolás
  • Polanska, Kinga
  • Rusconi, Franca
  • Santa Marina, Loreto
  • Santos, Ana Cristina
  • Vrijkotte, Tanja
  • Zugna, Daniela
  • Nieuwenhuijsen, Mark
  • Cordier, Sylvaine
  • Vrijheid, Martine
BACKGROUND: Women of reproductive age can be exposed to endocrine-disrupting chemicals (EDCs) at work and exposure to EDCs in pregnancy may affect fetal growth. OBJECTIVES: We assessed whether maternal occupational exposure to EDCs during pregnancy as classified by application of a job exposure matrix was associated with birth weight, term low birth weight (LBW), length of gestation, and preterm delivery. METHODS: Using individual participant data from 133,957 mother-child pairs in 13 European cohorts spanning births from 1994 to 2011, we linked maternal job titles with exposure to 10 EDC groups as assessed through a job exposure matrix. For each group, we combined the two levels of exposure categories (possible and probable) and compared birth outcomes with the unexposed group (exposure unlikely). We performed meta-analyses of cohort-specific estimates. RESULTS: Eleven percent of pregnant women were classified as exposed to EDCs at work during pregnancy based on job title. Classification of exposure to one or more EDC group was associated with an increased risk of term LBW (OR 1.25, 95%CI 1.04, 1.49), as were most specific EDC groups; this association was consistent across cohorts. Further, the risk increased with increasing number of EDC groups (OR 2.11 95%CI 1.10, 4.06 for exposure to 4 or more EDC groups). There were few associations (p < 0.05) with the other outcomes; women holding job titles classified as exposed to bisphenol A or brominated flame retardants were at higher risk for longer length of gestation. CONCLUSION: Results from our large population-based birth cohort design indicate that employment during pregnancy in occupations classified as possibly or probably exposed to EDCs was associated with an increased risk of term LBW.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association of gestational weight gain with adverse maternal and infant outcomes

  • LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group
Importance: Both low and high gestational weight gain have been associated with adverse maternal and infant outcomes, but optimal gestational weight gain remains uncertain and not well defined for all prepregnancy weight ranges. Objectives: To examine the association of ranges of gestational weight gain with risk of adverse maternal and infant outcomes and estimate optimal gestational weight gain ranges across prepregnancy body mass index categories. Design, setting, and participants: Individual participant-level meta-analysis using data from 196 670 participants within 25 cohort studies from Europe and North America (main study sample). Optimal gestational weight gain ranges were estimated for each prepregnancy body mass index (BMI) category by selecting the range of gestational weight gain that was associated with lower risk for any adverse outcome. Individual participant-level data from 3505 participants within 4 separate hospital-based cohorts were used as a validation sample. Data were collected between 1989 and 2015. The final date of follow-up was December 2015. Exposures: Gestational weight gain. Main outcomes and measures: The main outcome termed any adverse outcome was defined as the presence of 1 or more of the following outcomes: preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, and small or large size for gestational age at birth. Results: Of the 196 670 women (median age, 30.0 years [quartile 1 and 3, 27.0 and 33.0 years] and 40 937 were white) included in the main sample, 7809 (4.0%) were categorized at baseline as underweight (BMI <18.5); 133 788 (68.0%), normal weight (BMI, 18.5-24.9); 38 828 (19.7%), overweight (BMI, 25.0-29.9); 11 992 (6.1%), obesity grade 1 (BMI, 30.0-34.9); 3284 (1.7%), obesity grade 2 (BMI, 35.0-39.9); and 969 (0.5%), obesity grade 3 (BMI, ≥40.0). Overall, any adverse outcome occurred in 37.2% (n = 73 161) of women, ranging from 34.7% (2706 of 7809) among women categorized as underweight to 61.1% (592 of 969) among women categorized as obesity grade 3. Optimal gestational weight gain ranges were 14.0 kg to less than 16.0 kg for women categorized as underweight; 10.0 kg to less than 18.0 kg for normal weight; 2.0 kg to less than 16.0 kg for overweight; 2.0 kg to less than 6.0 kg for obesity grade 1; weight loss or gain of 0 kg to less than 4.0 kg for obesity grade 2; and weight gain of 0 kg to less than 6.0 kg for obesity grade 3. These gestational weight gain ranges were associated with low to moderate discrimination between those with and those without adverse outcomes (range for area under the receiver operating characteristic curve, 0.55-0.76). Results for discriminative performance in the validation sample were similar to the corresponding results in the main study sample (range for area under the receiver operating characteristic curve, 0.51-0.79). Conclusions and relevance: In this meta-analysis of pooled individual participant data from 25 cohort studies, the risk for adverse maternal and infant outcomes varied by gestational weight gain and across the range of prepregnancy weights. The estimates of optimal gestational weight gain may inform prenatal counseling; however, the optimal gestational weight gain ranges had limited predictive value for the outcomes assessed., Avon Longitudinal Study of Parents and Children (ALSPAC): Funded by grant 102215/2/13/2 from the UK Medical Research Council and Wellcome, core support from the University of Bristol, grant R01 DK10324 from the US National Institutes of Health, grant agreement 669545 from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013), award MC_UU_12013/5 from the UK Medical Research Council, and Dr Lawlor is a National Institute for Health Research senior investigator (NF-SI-0611-10196). Cohort of Newborns in Emilia Romagna (CoNER): No funding reported. Danish National Birth Cohort (DNBC): The Danish Epidemiology Science Centre initiated and created the DNBC and this center was established by the Danish National Research Foundation via a major grant. Additional support was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The 7-year follow-up study was supported by award 195/04 from the Lundbeck Foundation and award SSVF 0646 from the Danish Medical Research Council. Étude des Déterminants pré et postnatals du développement et de la santé de l’ENfant (EDEN): Supported by the French foundation for medical research, the French national agency for research, the French national institute for research in public health (IRESP: TGIR cohorte santé 2008 program), the French ministry of health, the French ministry of research, the INSERM bone and joint diseases national research and human nutrition national research programs, Paris-Sud University, Nestlé, the French national institute for population health surveillance, the French national institute for health education, the European Union FP7 programs (2007-2013; HELIX, ESCAPE, ENRIECO, and Medall projects), the French diabetes national research program through a collaboration with the French association of diabetic patients, the French agency for environmental health safety (now ANSES), the Mutuelle Générale de l’Education Nationale (a complementary health insurance), the French national agency for food security, and the French-speaking association for the study of diabetes and metabolism. Family and Children of Ukraine (FCOU): Supported by the Fogarty International Center at the US National Institutes of Health, the US National Institute of Environmental Health Sciences, the US Centers for Disease Control and Prevention, the US Environmental Protection Agency, and the National Academy of Medical Sciences of Ukraine. Genetica e Ambiente: Studio Prospettico dell’Infanzia in Italia (GASPII): Supported by the Italian ministry of health. Groningen Expert Center for Kids with Obesity (GECKO Drenthe): Supported by an unrestricted grant from Hutchison Whampoa Ltd and funding from the University of Groningen, Well Baby Clinic Foundation Icare, Noordlease, the Paediatric Association of the Netherlands, and Youth Health Care Drenthe. Genetics of Glucose regulation in Gestation and Growth (Gen3G): Supported by operating grant 20697 from the Fonds de recherche du Québec en santé, operating grant MOP 115071 from the Canadian Institute of Health Reseach, a grant from Diabète Québec, and operating grant OG-3-08-2622-JA from the Canadian Diabetes Association. Generation R: The general design of the study received financial support from Erasmus MC, University Medical Center Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development, the Netherlands Organisation for Scientific Research and the Ministry of Health, Welfare, and Sport, and the Ministry of Youth and Families. The research leading to these results received funding from the European Union Horizon 2020 Research and Innovation Programme under grant 733206 (LifeCycle Project). Dr Jaddoe received grant ERC-2014-CoG-648916 from the European Research Council. Dr Gaillard received grant 2017T013 from the Dutch Heart Foundation, grant 2017.81.002 from the Dutch Diabetes Foundation, and grant 543003109 from the Netherlands Organisation for Health Research and Development. Generation XXI: Funded by Programa Operacional de Saúde–Saúde XXI, Quadro Comunitário de Apoio III and Administração Regional de Saúde Norte (Regional Department of Ministry of Health), by POCI-01-0145-FEDER-016837 through the Operational Programme Competitiveness and Internationalization and national funding from the Foundation for Science and Technology (Portuguese Ministry of Science, Technology, and Higher Education) under the project PathMOB, by FCT PTDC/DTP-EPI/3306/2014 (Risco cardiometabólico na infância: desde o início da vida ao fim da infância), by POCI-01-0145-FEDER-006862 and UID/DTP/04750/2013 (Unidade de Investigação em Epidemiologia-Instituto de Saúde Pública da Universidade do Porto), and FCT investigator contract IF/01060/2015 awarded to Dr A. C. Santos. Growth, Exercise and Nutrition Epidemiological Study In preSchoolers (GENESIS): Supported by a research grant from Friesland Hellas. German Infant Nutritional Intervention plus environmental and genetic influences (GINIplus): Supported for the first 3 years by the Federal Ministry for Education, Science, Research, and Technology (intervention group) and Helmholtz Zentrum Munich (observation group). The 4-, 6-, 10-, and 15-year follow-up examinations were covered from the respective budgets of the 5 study centers (Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, LMU Munich, TU Munich, IUF-Leibniz Research-Institute for Environmental Medicine at the University of Düsseldorf) and by funding from the European Commission 7th Framework Programme (MeDALL project), Mead Johnson, and Nestlé and grant FKZ 20462296 from the Federal Ministry for Environment (awarded to IUF Düsseldorf). Norwegian Human Milk Study (HUMIS): Funded by award FP7/2007-2013 from the European Commission 7th Framework Programme, grant 289346 from European Union EarlyNutrition project, and by funds for project 213148 from the Norwegian Research Council’s MILPAAHEL programme. INfancia y Medio Ambiente (INMA)-Sabadell: Funded by grant Red INMA G03/176 from the Instituto de Salud Carlos III in Spain and grant 1999SGR 00241 from the Generalitat de Catalunya-CIRIT. INMA-Valencia: Funded by grants FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1 from the European Commission, grants G03/176, FIS-FEDER PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, Miguel Servet FEDER CP11/00178, CP15/00025, and CPII16/00051 from the Instituto de Salud Carlos III in Spain, and grants UGP 15-230, UGP-15-244, and UGP-15-249 from the Generalitat Valenciana, Foundation for the Promotion of Health and Biomedical Research of Valencia Region. INMA-Gipuzkoa: Funded by grants FISFIS PI06/0867, FIS-PS09/0009 0867, and Red INMA G03/176 from the Instituto de Salud Carlos III in Spain, grants 2005111093 and 2009111069 from the Departamento de Salud del Gobierno Vasco, and grants DFG06/004 and FG08/001 from the Provincial Government of Guipúzcoa. INMA-Menorca: This study was funded by grant Red INMA G03/176 from the Instituto de Salud Carlos III in Spain. Child, parents and health: lifestyle and genetic constitution (KOALA): Data collection from pregnancy up to the age of 1 year was supported by grants from Royal Friesland Foods, the Triodos Foundation, the Phoenix Foundation, the Raphaël Foundation, the Iona Foundation, the Foundation for the Advancement of Heilpedagogie, the Netherlands Organisation for Health Research and Development (2100.0090), the Netherlands Asthma Foundation (3.2.03.48 and 3.2.07.022), and the Netherlands Heart Foundation (2008B112). Krakow Cohort: Funded by grants R01ES010165 and R01ES015282 from the US National Institute of Environmental Health Sciences and by funding from the Lundin Foundation, the John and Wendy Neu Family Foundation, the Gladys and Roland Harriman Foundation, and the Anonymous Foundation. Influences of Lifestyle-Related Factors on the Immune System and the Development of Allergies in Childhood plus the influence of traffic emissions and genetics (LISAplus): Mainly supported by grants for the first 2 years from the Federal Ministry for Education, Science, Research, and Technology, the Helmholtz Zentrum Munich, the Helmholtz Centre for Environmental Research-UFZ, the Research Institute at Marien-Hospital Wesel, and a pediatric practice in Bad Honnef. The 4-, 6-, 10-, and 15-year follow-up examinations were funded by the respective budgets of the involved partners (the Helmholtz Zentrum Munich, the Helmholtz Centre for Environmental Research-UFZ, the Research Institute at Marien-Hospital Wesel, a pediatric practice in Bad Honnef, and the IUF–Leibniz-Research Institute for Environmental Medicine at the University of Düsseldorf), by grant FKZ 20462296 from the Federal Ministry for Environment (awarded to IUF Düsseldorf), and by support from the European Commission 7th Framework Programme (MeDALL project). LUKAS Cohort: Funded by EVO/VTR grants, grants 139021 and 287675 from the Academy of Finland, grant QLK4-CT-2001-00250 from the European Union, and funding from the Juho Vainio Foundation, the Foundation for Pediatric Research, the Päivikki and Sakari Sohlberg Foundation, the Finnish Cultural Foundation, and the National Institute for Health and Welfare in Finland. Norwegian Mother and Child Cohort Study (MoBa): Supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, contract N01-ES-75558 with the US National Institute of Environmental Health Sciences, and grants UO1 NS 047537-01 and UO1 NS 047537-06A1 from the US National Institute of Neurological Disorders and Stroke. Nascita e INFanzia: gli Effetti dell’Ambiente (NINFEA): Partially funded by the Compagnia San Paolo Foundation and by the Piedmont Region. Prevention and Incidence of Asthma and Mite Allergy (PIAMA): Supported by the Organization for Health Research and Development, the Organization for Scientific Research, the Asthma Fund, the Ministry of Spatial Planning, Housing, and the Environment, and the Ministry of Health, Welfare, and Sport (all organizations in the Netherlands). Piccolipiù Project: Financially supported by CCM grants during 2010 and 2014 from the Italian National Center for Disease Prevention and Control and funding (art 12 and 12 bis D.lgs 502/92) from the Italian Ministry of Health. PRegnancy and Infant DEvelopment (PRIDE Study): Supported by grants from the Netherlands Organization for Health Research and Development, the Radboud Institute for Health Sciences, and the Lung Foundation Netherlands. Project Viva: Funded by grants R01 HD034568 and UG3OD023286 from the US National Institutes of Health. Polish Mother and Child Cohort Study (REPRO_PL): Funded by grants DEC-2014/15/B/NZ7/00998 and FP7 HEALS 603946 from the National Science Centre in Poland and grant 3068/7.PR/2014/2 from the Polish Ministry of Science and Higher Education. Exposure of Preschool-Age Greek Children (RHEA): Financially supported by European Commission projects FP6-2003-Food-3-NewGeneris, FP6-STREP Hiwate, FP7-ENV.2007.1.2.2.2, FP7-2008-ENV-1.2.1.4 Envirogenomarkers, FP7-HEALTH-2009-single stage CHICOS, FP7-ENV.2008.1.2.1.6, FP7-HEALTH-2012, and 211250-Escape and proposals 226285 ENRIECO and 308333 HELIX and by the Greek Ministry of Health. Slovak PCB Study: Support was provided by grants R01 CA096525, R03 TW007152, P30 ES001247, P30 ES023513, and K12 ES019852 from the US National Institutes of Health. STEPS: This study was supported by the University of Turku, Abo Akademi University, the Turku University Hospital, the City of Turku, the Juho Vainio Foundation, and the Yrjö Jahnsson Foundation and by grants 121569 and 123571 from the Academy of Finland. Southampton Women’s Survey (SWS): Supported by funding from the Medical Research Council, the National Institute for Health Research Southampton Biomedical Research Centre, the University of Southampton, Dunhill Medical Trust, and the University Hospital Southampton National Health Service Foundation Trust, FP7/2007-2013 from the European Commission 7th Framework Programme, and grant 289346 from the European Union EarlyNutrition project.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts

  • Abellan, Alicia
  • Garcia-Esteban, Raquel
  • García Aymerich, Judith
  • Sunyer Deu, Jordi
  • Vrijheid, Martine
  • Casas Sanahuja, Maribel
Background: In utero exposure to bisphenols, widely used in consumer products, may alter lung development and increase the risk of respiratory morbidity in the offspring. However, evidence is scarce and mostly focused on bisphenol A (BPA) only. Objective: To examine the associations of in utero exposure to BPA, bisphenol F (BPF), and bisphenol S (BPS) with asthma, wheeze, and lung function in school-age children, and whether these associations differ by sex. Methods: We included 3,007 mother-child pairs from eight European birth cohorts. Bisphenol concentrations were determined in maternal urine samples collected during pregnancy (1999-2010). Between 7 and 11 years of age, current asthma and wheeze were assessed from questionnaires and lung function by spirometry. Wheezing patterns were constructed from questionnaires from early to mid-childhood. We performed adjusted random-effects meta-analysis on individual participant data. Results: Exposure to BPA was prevalent with 90% of maternal samples containing concentrations above detection limits. BPF and BPS were found in 27% and 49% of samples. In utero exposure to BPA was associated with higher odds of current asthma (OR = 1.13, 95% CI = 1.01, 1.27) and wheeze (OR = 1.14, 95% CI = 1.01, 1.30) (p-interaction sex = 0.01) among girls, but not with wheezing patterns nor lung function neither in overall nor among boys. We observed inconsistent associations of BPF and BPS with the respiratory outcomes assessed in overall and sex-stratified analyses. Conclusion: This study suggests that in utero BPA exposure may be associated with higher odds of asthma and wheeze among school-age girls., The research leading to these results has received funding from Instituto de Salud Carlos III and European Union’s FEDER funds (CP16/00128 – the ENDOLUNG project, and PI17/01194 – the INMA-Ado-Respi Project), the European Community’s Seventh Framework Programme (FP7/2007–206) under grant agreement no 308,333 - the HELIX project –, and from the EC’s Horizon 2020 research and innovation programme under grant agreement No 874,583 – the ATHLETE project. Generation R: This study was funded by The Erasmus MC, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. The project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583). Dr. Vincent Jaddoe received a grant from the European Research Council (ERC-2014-CoG-648916). This study was supported by grant R01-ES022972 and R01-ES029779 from the National Institutes of Health, USA. The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report. INMA Gipuzkoa: This study was funded by grants from Instituto de Salud Carlos III (FIS-PI13/02187 and FIS-PI18/01142 incl. FEDER funds), CIBERESP, Department of Health of the Basque Government (2015111065), and the Provincial Government of Gipuzkoa (DFG15/221) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain). INMA Sabadell: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), European Commission (261357, 308333, 603,794 and 634453). Alicia Abellan holds a LifeCycle fellowship, funded from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733206. Maribel Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and co-funded by European Social Fund “Investing in your future“. We acknowledge support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (2018–000806-S), and support from the Generalitat de Catalunya through the CERCA Program. INMA Valencia: INMA Valencia was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/00663, and PI19/1338; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), Alicia Koplowitz Foundation, and Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15–244, UGP-15–249, and AICO/2020/285). BiB: This report is independent research funded by the National Institute for Health Research Yorkshire and Humber ARC (NIHR200166) and BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA). The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. EDEN: The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007–2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. RHEA: The Rhea project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 ENV.2007.1.2.2.2. Project No 211,250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226,285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308,333 HELIX, H2020 LIFECYCLE, grant agreement No 733206, H2020 ATHLETE, grant agreement No 874583), and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012–15). Additional funding from NIEHS supported Dr Chatzi (R01ES030691, R01ES029944, R01ES030364, R21ES029681, R21ES028903, and P30ES007048). The funding sources had no involvement in the study design, the collection, analysis and interpretation of data or in the writing of the report and in the decision to submit the article for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits

  • Vogelezang, Suzanne
  • Vilor Tejedor, Natàlia, 1988-
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Sunyer Deu, Jordi
  • Felix, Janine Frédérique
The genetic background of childhood body mass index (BMI), and the extent to which the well-known associations of childhood BMI with adult diseases are explained by shared genetic factors, are largely unknown. We performed a genome-wide association study meta-analysis of BMI in 61,111 children aged between 2 and 10 years. Twenty-five independent loci reached genome-wide significance in the combined discovery and replication analyses. Two of these, located near NEDD4L and SLC45A3, have not previously been reported in relation to either childhood or adult BMI. Positive genetic correlations of childhood BMI with birth weight and adult BMI, waist-to-hip ratio, diastolic blood pressure and type 2 diabetes were detected (Rg ranging from 0.11 to 0.76, P-values <0.002). A negative genetic correlation of childhood BMI with age at menarche was observed. Our results suggest that the biological processes underlying childhood BMI largely, but not completely, overlap with those underlying adult BMI. The well-known observational associations of BMI in childhood with cardio-metabolic diseases in adulthood may reflect partial genetic overlap, but in light of previous evidence, it is also likely that they are explained through phenotypic continuity of BMI from childhood into adulthood., SFAG is supported by the Daniel B. Burke Chair for Diabetes Research and NIH Grant R01 HD058886. NVT is funded by a pre-doctoral grant from the Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 FI_B 00636), Generalitat de Catalunya – Fons Social Europeu. BK received personal funding from the European Research Council Advanced Grant META-GROWTH (ERC-2012-AdG – no. 322605). BF was supported by an Oak Foundation Fellowship. RMF and RNB are supported by Sir Henry Dale Fellowship (Wellcome Trust and Royal Society grant: WT104150). ATH is supported by a Wellcome Trust Senior Investigator award (grant number 098395/Z/12/Z). DM is supported by a Canada Research Chair. DLC was supported by the American Diabetes Association Grant 1-17-PDF-077. JTL was supported by the Finnish Cultural Foundation. DIB received a KNAW Academy Professor Award (PAH/6635). MH received PhD scholarship funding from TARGET (http://target.ku.dk), The Danish Diabetes Academy (http://danishdiabetesacademy.dk) and the Copenhagen Graduate School of Health and Medical Sciences. VWVJ received funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (ERC-2014-CoG-648916). ISF was supported by the European Research Council, Wellcome Trust (098497/Z/12/Z), Medical Research Council (MRC_MC_UU_12012/5), the NIHR Cambridge Biomedical Research Centre, the Botnar Foundation, the Bernard Wolfe Health Neuroscience Endowment and the European Community’s Seventh Framework Programme (FP7/2007-2013) project Beta-JUDO n°279153.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration

  • Liu, Xueping
  • Bustamante Pineda, Mariona
  • Vrijheid, Martine
  • Feenstra, Bjarke
The duration of pregnancy is influenced by fetal and maternal genetic and non-genetic factors. Here we report a fetal genome-wide association meta-analysis of gestational duration, and early preterm, preterm, and postterm birth in 84,689 infants. One locus on chromosome 2q13 is associated with gestational duration; the association is replicated in 9,291 additional infants (combined P = 3.96 × 10-14). Analysis of 15,588 mother-child pairs shows that the association is driven by fetal rather than maternal genotype. Functional experiments show that the lead SNP, rs7594852, alters the binding of the HIC1 transcriptional repressor. Genes at the locus include several interleukin 1 family members with roles in pro-inflammatory pathways that are central to the process of parturition. Further understanding of the underlying mechanisms will be of great public health importance, since giving birth either before or after the window of term gestation is associated with increased morbidity and mortality., We are grateful for the cooperation of the EGG Consortium and the iPSYCH-BROAD Working Group. Lists of members of the EGG Consortium and collaborators in the iPSYCH-BROAD Working Group are given in the Supplementary Notes 1 and 2, respectively. For study-specific acknowledgements, please see Supplementary Note 3. B.F. received support from an Oak Foundation fellowship, a Novo Nordisk Foundation grant (12955), and a Bill and Melinda Gates Foundation subward (137097); X.L. received support from the Nordic Center of Excellence in Health-Related e-Sciences; D.H., V.A., A.J.S., R.N., T.M.W., and A.D.B. recieved funding from the Lundbeck Foundation (R102-A9118, R155-2014-1724, R248-2017-2003); L.S. reports funding from a Carlsberg Foundation postdoctoral fellowship (CF15-0899); R.M.F. is a Sir Henry Dale Fellow (Wellcome and Royal Society grant: WT104150); R.N.B. is funded by Wellcome and Royal Society (grant: WT104150); M.C.B. and D.A.L. work in a unit that receives UK MRC funding (MC_UU_00011/6); M.C.B. is supported by the MRC Skills Development Fellowship MR/P014054/1; D.A.L.’s contribution to this work was funded by grants from the US NIH and European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013)/ERC Grant Agreement (Grant number 669545; DevelopObese) and European Union’s Horizon 2020 research and innovation programme under grant agreement 733206 (LIFECYCLE); D.A.L. is also an NIHR senior investigator (NF-SI-0611-10,196); F.R. received partial funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.367); J.F.F. and V.W.V.J. received partial funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements 733206 (LIFECYCLE) and 633595 (DynaHEALTH); V.W.V.J. received partial funding from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and the European Research Council (ERC Consolidator Grant, ERC-2014-CoG-648916); I.K. reports funding from Sigrid Juselius Foundation and Biomendicum Foundation postdoctoral fellowship; L.J.M. was supported by the March of Dimes Prematurity Research Center Ohio Collaborative, NICHD HD 091527, and the Bill and Melinda Gates Foundation (OPP1113966); M.T.W. was supported by NIH R01 NS099068, NIH R01 GM055479-19A1, a Lupus Research Alliance Novel Approaches award, CCRF Endowed Scholar, a CCHMC CpG Pilot study award, and a CCHMC Trustee award; K.K.R. received support from March of Dimes (21-FY13-19); C.P. was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre; M.I.M. is a Wellcome Senior Investigator and a NIHR Senior Investigator. His work is supported by Wellcome (090532, 093831, 203141, 106130) and by the NIH (U01DK105535). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. For study-specific funding, please see Supplementary Note 4.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gestational organophosphate pesticide exposure and childhood cardiovascular outcomes

  • Stevens, Danielle R.
  • Blaauwendraad, Sophia M.
  • Bommarito, Paige A.
  • van den Dries, Michiel
  • Trasande, Leonardo
  • Spaan, Suzanne
  • Pronk, Anjoeka
  • Tiemeier, Henning
  • Gaillard, Romy
  • Jaddoe, Vincent W. V.
  • Ferguson, Kelly K.
Introduction: The general population is chronically exposed to organophosphate pesticides through various routes including ingestion, hand-to-mouth contact, inhalation, and dermal contact. Exposure to organophosphate pesticides during pregnancy impairs fetal development, but the potential long-term effects of gestational organophosphate pesticide exposure are less well understood. Methods: We investigated associations between gestational organophosphate pesticide exposure and cardiovascular outcomes in 643 children in the Generation R Study, a prospective pregnancy cohort based in Rotterdam, The Netherlands. Urinary organophosphate pesticide metabolites (dimethyl [∑DMAP], diethyl [∑DEAP], and total dialkyl phosphate [∑DAP] metabolites) were quantified in three urine samples collected from pregnant participants, and their children were followed until age 10 years at which time cardiac magnetic resonance imaging, ultrasonography, blood pressure, and serum biomarkers assessed cardiovascular health. Linear regression models estimated associations (β and 95 % confidence interval [CI]) between a one-interquartile range (IQR) increase in averaged gestational exposure biomarker concentrations and z-scored pediatric cardiovascular outcomes. We investigated effect modification of associations by PON1 genotype. Results: Carotid intima-media thickness z-score was lower (β: -0.14 [95 % CI: -0.25, -0.02]) and HDL cholesterol z-score was higher (β: 0.14 [95 % CI: 0.02, 0.25]) for increases in ∑DEAP concentrations. Carotid intima-media distensibility z-score was lower (β: -0.08 [95 % CI: -0.19, 0.03]) for increases in ∑DMAP concentrations, and systolic blood pressure z-score was higher (β: 0.10 [95 % CI: -0.01, 0.21]) for increases in ∑DMAP and ∑DAP. Among those with PON1-161CC and PON1-L55MTT genotypes, higher organophosphate pesticide concentrations conferred an excess risk of adverse vascular and glycemic outcomes, respectively. Conclusions: We observed heterogenous associations between gestational organophosphate pesticide exposure and pediatric cardiovascular health: an anti-atherogenic profile was observed for increases in ∑DEAP concentrations, and impairments in multiple aspects of cardiovascular health was observed for increases in ∑DMAP concentrations. PON1-161 and PON1-L55M single nucleotide polymorphisms modified associations for vascular and glycemic outcomes, respectively., This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) (ZIAES101575) and a research and development contract (HHSN273201500003C). The Generation R Study is financially supported by the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. DRS received a grant from the NIEHS through award number 1K99ES035107-01. VWVJ received a grant from the Netherlands Organization for Health Research and Development (NWO, ZonMw-VIDI 016.136.361) and a European Research Council Consolidator Grant (ERC-2014-CoG-648916). H.T. was supported by the Netherlands Organization for Scientific Research (NWO) VICI grant (NWO-ZonMW: 016. VICI.170.200). RG received funding from the Dutch Diabetes Foundation (grant number 2017.81.002), the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109, NWO, ZonMw 09150172110034) and from the European Union’s Horizon 2020 research and innovation program under the ERA-NET Cofund action (no 727565), EndObesity, ZonMW the Netherlands (no. 529051026). LT was supported by NIEHS grants (R01ES022972 and R01ES029779). This project has additionally received funding from the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL), EndObesity, ZonMW Netherlands (No. 529051026). Furthermore, this work was supported by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 733,206 (LifeCycle), 874,583 (ATHLETE) and 824,989 (EUCAN-Connect), the Spanish Ministry of Science and Innovation and the State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and the Generalitat de Catalunya through the CERCA Program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics

  • Beaumont, Robin N.
  • Warrington, Nicole M.
  • Cavadino, Alana
  • Tyrrell, Jessica
  • Nodzenski, Michael
  • Horikoshi, Momoko
  • Geller, Frank
  • Myhre, Ronny
  • Richmond, Rebecca C.
  • Paternoster, Lavinia
  • Bradfield, Jonathan P.
  • Kreiner-Moller, Eskil
  • Huikari, Ville
  • Metrustry, Sarah
  • Lunetta, Kathryn L.
  • Painter, Jodie N.
  • Hottenga, Jouke-Jan
  • Allard, Catherine
  • Barton, Sheila J.
  • Espinosa Cardiel, Ana
  • Marsh, Julie A.
  • Potter, Catherine
  • Zhang, Ge
  • Ang, Wei
  • Berry, Diane J.
  • Bouchard, Luigi
  • Das, Shikta
  • Early Growth Genetics (EGG) Consortium
  • Hakonarson, Hakon
  • Heikkinen, Jani
  • Helgeland, Øyvind
  • Hocher, Berthold
  • Hofman, Albert
  • Inskip, Hazel M.
  • Jones, Samuel E.
  • Kogevinas, Manolis
  • Lind, Penelope A.
  • Marullo, Letizia
  • Medland, Sarah E.
  • Murray, Anna
  • Murray, Jeffrey C.
  • Njolstad, Pal R.
  • Nohr, Ellen Aagard
  • Reichetzeder, Christoph
  • Ring, Susan M.
  • Ruth, Katherine S.
  • Santa Marina, Loreto
  • Scholtens, Denise M.
  • Sebert, Sylvain
  • Sengpiel, Verena
  • Tuke, Marcus A.
  • Vaudel, Marc
  • Weedon, Michael N.
  • Willemsen, Gonneke
  • Wood, Andrew R.
  • Yaghootkar, Hanieh
  • Muglia, Louis J.
  • Bartels, Meike
  • Relton, Caroline L.
  • Pennell, Craig E.
  • Chatzi, Leda
  • Estivill, Xavier, 1955-
  • Holloway, John W.
  • Boomsma, Dorret I.
  • Montgomery, Grant W.
  • Murabito, Joanne M.
  • Spector, Tim D.
  • Power, Christine
  • Järvelin, Marjo-Ritta
  • Bisgaard, Hans
  • Grant, Struan F.
  • Sorensen, Thorkild I. A.
  • Jaddoe, Vincent W.
  • Jacobsson, Bo
  • Melbye, Mads
  • McCarthy, Mark I.
  • Hattersley, Andrew T.
  • Hayes, M. Geoffrey
  • Frayling, Timothy M.
  • Hivert, Marie-France
  • Felix, Janine F.
  • Hyppönen, Elina
  • Lowe, William L.
  • Evans, David M.
  • Lawlor, Debbie A.
  • Feenstra, Bjarke
  • Freathy, Rachel M.
Genome-wide association studies of birth weight have focused on fetal genetics, whereas relatively little is known about the role of maternal genetic variation. We aimed to identify maternal genetic variants associated with birth weight that could highlight potentially relevant maternal determinants of fetal growth. We meta-analysed data on up to 8.7 million SNPs in up to 86 577 women of European descent from the Early Growth Genetics (EGG) Consortium and the UK Biobank. We used structural equation modelling (SEM) and analyses of mother–child pairs to quantify the separate maternal and fetal genetic effects. Maternal SNPs at 10 loci (MTNR1B, HMGA2, SH2B3, KCNAB1, L3MBTL3, GCK, EBF1, TCF7L2, ACTL9, CYP3A7) were associated with offspring birth weight at P < 5 × 10−8. In SEM analyses, at least 7 of the 10 associations were consistent with effects of the maternal genotype acting via the intrauterine environment, rather than via effects of shared alleles with the fetus. Variants, or correlated proxies, at many of the loci had been previously associated with adult traits, including fasting glucose (MTNR1B, GCK and TCF7L2) and sex hormone levels (CYP3A7), and one (EBF1) with gestational duration. The identified associations indicate that genetic effects on maternal glucose, cytochrome P450 activity and gestational duration, and potentially on maternal blood pressure and immune function, are relevant for fetal growth. Further characterization of these associations in mechanistic and causal analyses will enhance understanding of the potentially modifiable maternal determinants of fetal growth, with the goal of reducing the morbidity and mortality associated with low and high birth weights.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cohort profile: Pregnancy and childhood epigenetics (PACE) consortium

  • Felix, Janine Frédérique
  • Kogevinas, Manolis
  • Sunyer Deu, Jordi
  • Vrijheid, Martine
  • London, Stephanie J.
V.W.J. received a grant from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and a Consolidator grant from the European Research Council (ERC-2014-CoG-648916) [...]. Main funding of the epigenetic studies in INMA were grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041), Spanish Ministry of Health (FIS-PI04/1436, FIS-PI08/1151 including FEDER funds, FIS-PI11/00610, FIS-FEDER-PI06/0867, FIS-FEDER-PI03-1615) Generalitat de Catalunya-CIRIT 1999SGR 00241, Fundació La Marató de TV3 (090430), EU Commission (261357-MeDALL: Mechanisms of the Development of ALLergy), and European Research Council (268479-BREATHE: BRain dEvelopment and Air polluTion ultrafine particles in scHool childrEn) [...].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Maternal and fetal genetic contribution to gestational weight gain

  • Warrington, Nicole M.
  • Richmond, Rebecca C.
  • Fenstra, Bjarke
  • Myhre, Ronny
  • Gaillard, Romy
  • Paternoster, Lavinia
  • Wang, Carol A.
  • Beaumont, Robin N.
  • Das, Shikta
  • Murcia, Mario
  • Barton, Sheila J.
  • Espinosa Cardiel, Ana
  • Thiering, Elisabeth
  • Atalay, Mustafa
  • Pitkanen, Niina
  • Ntalla, Ioanna
  • Jonsson, Anna E.
  • Freathy, Rachel M.
  • Karhunen, Ville
  • Tiesler, Carla M. T.
  • Allard, Catherine
  • Crawford, Andrew
  • Ring, Susan M.
  • Melbye, Mads
  • Magnus, Per
  • Rivadeneira, Fernando
  • Skotte, Line
  • Hansen, Torben
  • Marsh, Julie A.
  • Guxens, Mònica
  • Holloway, John W.
  • Grallert, Harald
  • Jaddoe, Vincent W.
  • Lowe, William L.
  • Roumeliotaki, Theano
  • Hattersley, Andrew T.
  • Lindi, Virpi
  • Pahkala, Katja
  • Panoutsopoulou, Kalliope
  • Standl, Marie
  • Flexeder, Claudia
  • Bouchard, Luigi
  • Nohr, Ellen Aagard
  • Marina, Loreto Santa
  • Kogevinas, Manolis
  • Niinikoski, Harri
  • Dedoussis, George
  • Heinrich, Joachim
  • Reynolds, Rebecca M.
  • Lakka, Timo
  • Zeggini, Eleftheria
  • Raitakari, Olli T.
  • Chatzi, Leda
  • Inskip, Hazel M.
  • Bustamante Pineda, Mariona
  • Hivert, Marie-France
  • Jarvelin, Marjo-Riitta
  • Sorensen, Thorkild I. A.
  • Pennell, Craig E.
  • Felix, Janine F.
  • Jacobsson, Bo
  • Geller, Frank
  • Evans, David M.
  • Lawlor, Debbie A.
BACKGROUND: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG. PARTICIPANTS AND METHODS: A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (e.g. maternal BMI and glucose, birthweight). RESULTS: Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explaining variation in GWG. Variants near the Pregnancy Specific Beta-1-Glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 x 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birthweight variants were largely unrelated to GWG. CONCLUSION: We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.International Journal of Obesity accepted article preview online, 09 October 2017. doi:10.1038/ijo.2017.248.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Epigenome-Wide Meta-Analysis of Methylation in Children Related to Prenatal NO2 Air Pollution Exposure

  • Gruzieva, Olena
  • Xu, Cheng-Jian
  • Breton, Carrie V.
  • Annesi-Maesano, Isabella
  • Antó i Boqué, Josep Maria
  • Auffray, Charles
  • Ballereau, Stephane
  • Bellander, Tom
  • Bousquet, Jean
  • Bustamante Pineda, Mariona
  • Charles, Marie-Aline
  • Kluizenaar, Yvonne de
  • Dekker, Herman T. den
  • Duijts, Liesbeth
  • Felix, Janine F.
  • Gehring, Ulrike
  • Guxens, Mònica
  • Jaddoe, Vincent W.
  • Jankipersadsing, Soesma A.
  • Merid, Simon Kebede
  • Kere, Juha
  • Kumar, Ashish
  • Lemonnier, Nathanael
  • Lepeule, Johanna
  • Nystad, Wenche
  • Page, Christian Magnus
  • Panasevich, Sviatlana
  • Postma, Dirkje S.
  • Slama, Rémy
  • Sunyer Deu, Jordi
  • Soderhall, Cilla
  • Yao, Jin
  • London, Stephanie J.
  • Pershagen, Göran
  • Koppelman, Gerard H.
  • Melén, Erik
BACKGROUND: Prenatal exposure to air pollution is considered to be associated with adverse effects on child health. This may partly be mediated by mechanisms related to DNA methylation. OBJECTIVES: We investigated associations between exposure to air pollution, using nitrogen dioxide (NO2) as marker, and epigenome-wide cord blood DNA methylation. METHODS: We meta-analyzed the associations between NO2 exposure at residential addresses during pregnancy and cord blood DNA methylation (Illumina 450K) in four European and North-American studies (n=1,508) with subsequent look-up analyses in children aged 4 (n=733) and 8 (n=786) years. Additionally, we applied a literature-based candidate approach for antioxidant and anti-inflammatory genes. To assess influence of exposure at the transcriptomics level, we related mRNA expression in blood cells to NO2 exposure in 4- (n=111) and 16-year-olds (n=239). RESULTS: We found epigenome-wide significant associations (false discovery rate (FDR) p<0.05) between maternal NO2 exposure during pregnancy and DNA methylation in newborns for 3 CpG sites in mitochondria-related genes: cg12283362 (LONP1), cg24172570 (3.8 kbp upstream of HIBADH), and cg08973675 (SLC25A28). The associations with cg08973675 methylation were also significant in the older children. Further analysis of antioxidant and anti-inflammatory genes revealed differentially methylated CpGs in CAT and TPO in newborns (FDR p<0.05). NO2 exposure at the time of biosampling in childhood had significant impact on CAT and TPO expression. CONCLUSIONS: NO2 exposure during pregnancy was associated with differential offspring DNA methylation in mitochondria-related genes. Exposure to NO2 was also linked to differential methylation as well as expression of genes involved in antioxidant defense pathways.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: findings from the pregnancy and childhood epigenetics (PACE) consortium

  • Sharp, Gemma C.
  • Salas, Lucas A.
  • Monnereau, Claire
  • Allard, Catherine
  • Yousefi, Paul
  • Everson, Todd M.
  • Bohlin, Jon
  • Xu, Zongli
  • Huang, Rae-Chi
  • Reese, Sarah E.
  • Xu, Cheng-Jian
  • Baiz, Nour
  • Hoyo, Cathrine
  • Agha, Golareh
  • Roy, Ritu
  • Holloway, John W.
  • Ghantous, Akram
  • Merid, Simon Kebede
  • Bakulski, Kelly M.
  • Kupers, Leanne K.
  • Zhang, Hongmei
  • Richmond, Rebecca C.
  • Page, Christian Magnus
  • Duijts, Liesbeth
  • Lie, Rolv T.
  • Melton, Phillip E.
  • Vonk, Judith M.
  • Nohr, Ellen Aagard
  • Williams-DeVane, ClarLynda
  • Huen, Karen
  • Rifas-Shiman, Sheryl L.
  • Ruiz Arenas, Carlos
  • Gonseth, Semira
  • Rezwan, Faisal I.
  • Herceg, Zdenko
  • Ekstrom, Sandra
  • Croen, Lisa
  • Falahi, Fahimeh
  • Perron, Patrice
  • Karagas, Margaret R.
  • Quraishi, Bilal M.
  • Suderman, Matthew
  • Magnus, Maria C.
  • Jaddoe, Vincent W.
  • Taylor, Jack A.
  • Anderson, Denise
  • Zhao, Shanshan
  • Smit, Henriette A.
  • Josey, Michele J.
  • Bradman, Asa
  • Baccarelli, Andrea A.
  • Bustamante Pineda, Mariona
  • Haberg, Siri E.
  • Pershagen, Göran
  • Hertz-Picciotto, Irva
  • Newschaffer, Craig
  • Corpeleijn, Eva
  • Bouchard, Luigi
  • Lawlor, Debbie A.
  • Maguire, Rachel L.
  • Barcellos, Lisa F.
  • Davey Smith, George
  • Eskenazi, Brenda
  • Karmaus, Wilfried
  • Marsit, Carmen J.
  • Hivert, Marie-France
  • Snieder, Harold
  • Fallin, M. Daniele
  • Melén, Erik
  • Munthe-Kaas, Monica C.
  • Arshad, Hasan
  • Wiemels, Joseph L.
  • Annesi-Maesano, Isabella
  • Vrijheid, Martine
  • Oken, Emily
  • Holland, Nina
  • Murphy, Susan K.
  • Sorensen, Thorkild I. A.
  • Koppelman, Gerard H.
  • Newnham, John P.
  • Wilcox, Allen J.
  • Nystad, Wenche
  • London, Stephanie J.
  • Felix, Janine F.
  • Relton, Caroline L.
Pre-pregnancy maternal obesity is associated with adverse offspring outcomes at birth and later in life. Individual studies have shown that epigenetic modifications such as DNA methylation could contribute. Within the Pregnancy and Childhood Epigenetics (PACE) Consortium, we meta-analysed the association between pre-pregnancy maternal BMI and methylation at over 450,000 sites in newborn blood DNA, across 19 cohorts (9,340 mother-newborn pairs). We attempted to infer causality by comparing the effects of maternal versus paternal BMI and incorporating genetic variation. In four additional cohorts (1,817 mother-child pairs), we meta-analysed the association between maternal BMI at the start of pregnancy and blood methylation in adolescents. In newborns, maternal BMI was associated with small (<0.2% per BMI unit (1 kg/m2), P < 1.06 x 10-7) methylation variation at 9,044 sites throughout the genome. Adjustment for estimated cell proportions greatly attenuated the number of significant CpGs to 104, including 86 sites common to the unadjusted model. At 72/86 sites, the direction of the association was the same in newborns and adolescents, suggesting persistence of signals. However, we found evidence for acausal intrauterine effect of maternal BMI on newborn methylation at just 8/86 sites. In conclusion, this well-powered analysis identified robust associations between maternal adiposity and variations in newborn blood DNA methylation, but these small effects may be better explained by genetic or lifestyle factors than a causal intrauterine mechanism. This highlights the need for large-scale collaborative approaches and the application of causal inference techniques in epigenetic epidemiology.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Maternal caffeine consumption during pregnancy and offspring cord blood DNA methylation: an epigenome-wide association study meta-analysis

  • Schellhas, Laura
  • Monasso, Giulietta S.
  • Felix, Janine Frédérique
  • Jaddoe, Vincent W. V.
  • Huang, Peiyuan
  • Fernández-Barrés, Sílvia
  • Vrijheid, Martine
  • Pesce, Giancarlo
  • Annesi-Maesano, Isabella
  • Page, Christian M.
  • Brantsaeter, Anne Lise
  • Bekkhus, Mona
  • Håberg, Siri E.
  • London, Stephanie J.
  • Munafò, Marcus R.
  • Zuccolo, Luisa
  • Sharp, Gemma C.
Background: Prenatal caffeine exposure may influence offspring health via DNA methylation, but no large studies have tested this. Materials & methods: Epigenome-wide association studies and differentially methylated regions in cord blood (450k or EPIC Illumina arrays) were meta-analyzed across six European cohorts (n = 3725). Differential methylation related to self-reported caffeine intake (mg/day) from coffee, tea and cola was compared with assess whether caffeine is driving effects. Results: One CpG site (cg19370043, PRRX1) was associated with caffeine and another (cg14591243, STAG1) with cola intake. A total of 12-22 differentially methylated regions were detected with limited overlap across caffeinated beverages. Conclusion: We found little evidence to support an intrauterine effect of caffeine on offspring DNA methylation. Statistical power limitations may have impacted our findings., This research was also conducted as part of the Childhood and Adolescence Psychopathology: Unravelling the Complex Etiology by a Large Interdisciplinary Collaboration in Europe) project, funded by the EU’s Horizon 2020 research and innovation program, Marie Sklodowska Curie Actions – MSCA-ITN-2016 – Innovative Training Networks under grant agreement no. 721567. GC Sharp is financially supported by an MRC New Investigator Research (grant code MR/S009310/1), an MRC project grant (MR/W020297/1) and the European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL, NutriPROGRAM project, UK MRC MR/S036520/1). BiB: BiB receives core funding from the Wellcome Trust (WT101597MA), the British Heart Foundation (CS/16/4/32482), a joint grant from the UK MRC and UK Economic and Social Science Research Council (MR/N024397/1) and the National Institute for Health Research under its Collaboration for Applied Health Research and Care for Yorkshire and Humber. The research presented in this paper, including obtaining genome-wide and epigenome-wide DNA methylation data is supported by the US NIH (R01 DK10324) and European Research Council (ERC) under the EU’s Seventh Framework Programme (FP7/2007-2013) ERC grant agreement no. 669545. Generation R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, Erasmus University Rotterdam, The Netherlands Organization for Health Research and Development and the Ministry of Health, Welfare and Sport. The EWAS data were funded by a grant to VW Jaddoe from The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research Netherlands Consortium for Healthy Aging (project no. 050-060-810), by funds from the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC and by a grant from the National Institute of Child and Human Development (R01HD068437). VW Jaddoe received a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). This project received funding from the EU’s Horizon 2020 research and innovation program (733206, LifeCycle; 874739, LongITools; 874583, ATHLETE; 824989, EUCAN-Connect) and from the European JPI HDHL (NutriPROGRAM project, ZonMw The Netherlands no. 529051022 and PREcisE project ZonMw The Netherlands no. 529051023). MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. MoBa 1 and 2 were supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01-ES-49019), NIH/National Institute of Environmental Health Sciences contract no. N01-ES-75558, the Norwegian Research Council/BIOBANK (grant no. 221097). This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project no. 262700. Where authors are identified as personnel of the International Agency for Research on Cancer/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/WHO. INMA: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041, PI041436, PI081151 incl. FEDER funds), Generalitat de Catalunya-CIRIT 1999SGR 00241, Fundació La marató de TV3 (090430), EU Commission (261357-MeDALL: Mechanisms of the Development of Allergy), European Research Council (268479-BREATHE: Brain Development and Air Pollution Ultrafine Particles in School Children) and the European JPI HDHL (and Instituto de Salud Carlos III) under the grant agreement no. AC18/00006 (NutriPROGRAM project). We acknowledge support from the Spanish Ministry of Science and Innovation and the State Research Agency through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the Research Centres of Catalonia Program. EDEN: Foundation for Medical Research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the EU FP7 programs (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (in collaboration with the French Association of Diabetic Patients [AFD]), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale complementary health insurance, French National Agency for Food Security, French Speaking Association for the Study of Diabetes and Metabolism (ALFEDIAM), Sao Paulo Research Foundation (FAPESP) grant no. 2012/51290-6, and EU-funded MeDALL project. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ambient air pollution and childhood obesity from infancy to late childhood: An individual participant data meta-analysis of 10 European birth cohorts

  • Warkentin, Sarah
  • Fossati, Serena
  • Márquez, Sandra
  • Cadman, Tim
  • Casas Sanahuja, Maribel
  • Castro, Montserrat de
  • Guxens Junyent, Mònica
  • Nieuwenhuijsen, Mark J.
  • Vrijheid, Martine
Ambient air pollution may contribute to childhood obesity through various mechanisms. However, few longitudinal studies examined the relationship between pre- and postnatal exposure to air pollution and obesity outcomes in childhood. We aimed to investigate the association between pre- and postnatal exposure to air pollution and body mass index (BMI) and the risk of overweight/obesity throughout childhood in European cohorts. This study included mother-child pairs from 10 European birth cohorts (n = 37111 (prenatal), 33860 (postnatal)). Exposure to nitrogen dioxide (NO2) and fine particulate matter with aerodynamic diameter < 2.5 µm (PM2.5) was estimated at the home addresses during pre- and postnatal periods (year prior outcome assessment). BMI z-scores (continuous) and overweight/obesity status (categorical: zBMI≥+2 (<5 years) or ≥+1 (≥5 years) standard deviations) were derived at 0-2, 2-5, 5-9, 9-12 years. Associations between air pollution exposure and zBMI were estimated separately for each pollutant and cohort using linear and logistic longitudinal mixed effects models, followed by a random-effects meta-analysis. The overweight/obesity prevalence ranged from 12.3-40.5 % between cohorts at 0-2 years, 16.7-35.3 % at 2-5 years, 12.5-40.7 % at 5-9 years, and 10.7-43.8 % at 9-12 years. Results showed no robust associations between NO2 exposure and zBMI or overweight/obesity risk. Exposure to PM2.5 during pregnancy was associated with 23 % (95%CI 1.05;1.37) higher overweight/obesity risk across childhood, and higher zBMI and overweight/obesity risk at 9-12 years. Heterogeneity between cohorts was considerable (I2:25-89 %), with some cohort-specific associations; e.g., pre- and postnatal exposure to PM2.5 was associated with lower zBMI across age periods in UK cohorts (ALSPAC and BiB), while postnatal exposure to PM2.5 and NO2 was associated with higher zBMI in one Dutch cohort (Generation R). Overall, this large-scale meta-analysis suggests that prenatal PM2.5 exposure may be associated with adverse childhood obesity outcomes, but provides no evidence to support an effect of postnatal air pollution exposure, although cohort-specific associations were observed., The LifeCycle project received funding from the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 733,206 LifeCycle). This study was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874583 (ATHLETE project). ABCD: Core funding of the ABCD-study was provided by the Amsterdam University Medical center, Amsterdam, the Public Health Services, Amsterdam, and the Dutch Organization for Health Research and Development (ZonMw). ALSPAC: Core funding for the Avon Longitudinal Study of Parents and Children (ALSPAC) is provided by the UK Medical Research Council and Wellcome (217065/Z/19/Z) and the University of Bristol. A comprehensive list of grants funding is available on the ALSPAC website (https://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). BiB: Born in Bradford receives funding from by a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) [MR/N024391/1]; the British Heart Foundation [CS/16/4/32482]; a Wellcome Infrastructure Grant [WT101597MA]; the National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber [NIHR200166]; and was supported by UK Research and Innovation for the Healthy Urban Places consortium (grant reference MR/Y022785/1) as part of Population Health Improvement UK (PHI-UK), a national research network which works to transform health and reduce inequalities through change at the population level. The views expressed are those of the author(s), and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. DNBC: The Danish National Birth Cohort was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Health Foundation and other minor grants. The DNBC Biobank has been supported by the Novo Nordisk Foundation and the Lundbeck Foundation. Follow-up of mothers and children have been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B), the Lundbeck Foundation (195/04, R100-A9193), The Innovation Fund Denmark 0603-00294B (09-067124), the Nordea Foundation (02-2013-2014), Aarhus Ideas (AU R9-A959-13-S804), University of Copenhagen Strategic Grant (IFSV 2012), and the Danish Council for Independent Research (DFF – 4183-00594 and DFF − 4183-00152). EDEN: The EDEN study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French speaking association for the study of diabetes and metabolism (ALFEDIAM). Gen R: The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. This project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583; LongITools, grant agreement No 874739). VJ received funding from a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). INMA: This study was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176) and the Generalitat de Catalunya-CIRIT (1999SGR 00241). INMA-Valencia was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5-1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), and Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249). INMA-Gipuzkoa was funded by grants from the Instituto de Salud Carlos III (FISFIS PI06/0867, FISPS09/0009) 0867, Red INMA G03/176) and the Departamento de Salud del Gobierno Vasco (2005111093 and 2009111069) and the Provincial Government of Guipúzcoa (DFG06/004 and FG08/001). INMA-Sabadell was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds; PI15/00118 incl. FEDER funds; CP16/00128 incl. FEDER funds; PI16/00118 incl. FEDER funds; PI16/00261 incl. FEDER funds; PI17/01340 incl. FEDER funds; PI18/00547 incl. FEDER funds), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securité Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010; EST-2016 RF-21), EU Commission (261357, 308333, 603,794 and 634453). Mònica Guxens was funded by a Miguel Servet II fellowship (CPII18/00018) awarded by the Spanish Institute of Health Carlos III. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/https://doi.org/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. MoBa: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this on-going cohort study. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. This study includes data from the Norwegian Mother, Father and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. NINFEA: The NINFEA cohort was initially funded by the Compagnia SanPaolo Foundation and the Piedmont Region. It received funding from European projects: CHICOS (FP7 grant number HEALTH-FP7-2009-241604, LifeCycle (H2020 grant number 733206), ATHLETE (H2020 grant number 874583). RHEA: The “Rhea” project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 NV.2007.1.2.2.2. Project No 211,250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226,285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308,333 HELIX) and the Greek Ministry of Health (Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011-2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-15). SW acknowledges receiving the funding by the Generalitat de Catalunya (Agency for Management of University and Research Grants) with a Beatriu de Pinós post-doctoral fellowship (Ref: 2021 BP 00058). SS is supported by the European Uniońs Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie Postdoctoral Fellowship Grant Agreement No. 101,109,136 (URBANE). The funders had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.